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Abstract 
 
 
The United States Air Force has high volume biological air sampling equipment available 
including the XMX/2L-MIL and DFU-1000.  Neither system has been evaluated for 
effectiveness in the collection of viruses.  Furthermore, decontamination methods have 
not been evaluated for these systems after use in sampling for a viral agent.        
 
MS2 bacteriophage was used as a surrogate virus.  Aerosolized MS2 was released into a 
12 m3 exposure chamber.  High and moderate airborne concentrations of MS2 were 
evaluated.  Low volume impingers were used for comparative purposes as well.  Samples 
were analyzed using plaque assay and polymerase chain reaction (PCR).   
 
At high viral loads the XMX/2L-MIL and DFU-1000 achieved collection effectiveness 
equal to or greater than the low volume impingers.  At moderate levels of airborne viral 
load, the XMX/2L-MIL was capable of collecting viral quantities within 25% of the 
quantities collected by the low volume impingers.  The DFU-1000 achieved marginal 
collection effectiveness of virus at moderate concentrations compared to the XMX/2L-
MIL and is considered to be unreliable in the quantification of viral agent at moderate 
levels and below.  The DFU-1000 and XMX/2L-MIL were capable of collecting 
detectable MS2 with PCR analysis at all concentrations.  Ten percent sodium 
hypochlorite (commercial bleach) solution effectively decontaminated MS2.   
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HIGH VOLUME AIR SAMPLING FOR VIRAL AEROSOLS: A COMPARATIVE 
APPROACH 
 
I. Introduction 
 
Viral Disease and Biowarfare Overview 
Viral disease outbreaks have been the largest contributor to recent disease pandemics 
including the Severe Acute Respiratory Syndrome (SARS) virus, the H5N1 avian 
influenza, and most recently the H1N1 swine flu.  These disease outbreaks have caused 
widespread concern and often weigh heavily on public health resources.  The 2009 
outbreak of the H1N1 strain alone has resulted in 9,079 hospitalizations and 593 deaths 
worldwide as of September 4, 2009 (CDC, 2009).  In a nine month period from 
November 2002 to July 2003, over 8,000 people were infected with the SARS virus.  Of 
those infected, 774 died, giving SARS a mortality rate of 9.6 percent (WHO, 2004).  
Each of these recent viral disease outbreaks is capable of airborne transmission by viral 
aerosol, thus greatly increasing the incidence of new cases and rapidly facilitating their 
global spread.  Localized viral disease epidemics have also resulted in severe impacts to 
Air Force training and operations.  Outbreaks of Adenovirus Subtype 14 have persistently 
affected the basic training operations at Lackland Air Force Base, Texas.  These 
outbreaks resulted in two fatalities and numerous hospitalizations since 2007 and 
continue to cause illness in the training population.  New viruses and mutations of 
existing viruses are expected to present a challenge for the foreseeable future.     
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In addition to the emergence of naturally occurring viral disease causing agents, 
numerous potential bioterrorism agents are also capable of dissemination by viral aerosol.  
These agents include smallpox, viral hemorrhagic fever agents, and Venezuelan Equine 
Encephalitis (VEE).  The use of smallpox virus as a biological warfare agent can be 
traced back as early as the eighteenth century when blankets and clothing items from 
smallpox patients were given to Native Americans during the French and Indian War 
(Martin, Christopher, & Eitzen, 2007).  Consideration of smallpox and other viral agents 
as potential biological weapons continued into the modern era. The Soviet Union pursued 
a large clandestine program during the cold war that included weapons research on 
numerous viral agents including smallpox, Marburg, and VEE.  These agents were 
prepared in quantities sufficient for use in intercontinental ballistic missiles to 
disseminate the aerosolized virus over a large geographical area (Alibek, 1999).  Al-
Queda and other terrorist organizations also have expressed interest in developing, 
acquiring, and using biological weapons.  An Iraqi Al-Queda website expressed such 
interest with the following post in 2005:  
Biological weapons are considered the least complicated and the easiest to 
manufacture [of] all weapons of mass destruction. All the information 
concerning the production of these weapons is readily available in academic 
books, scholarly publications and even on the internet….In addition to the ease 
of production, these weapons are also considered to be the most affordable. With 
$50,000 a group of amateurs can possess a biological weapon sufficient to 
threaten a superpower. It is for this reason that biological weapons are called the 
poor man’s atomic weapon (Salama & Bursac, 2009). 
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Disease Life-Cycle Models, Transmission, and Control 
 The life cycle of all infectious disease can be evaluated through the use of the Host-
Agent-Environment (HAE) triad model.   This model provides the basic framework for 
preventing the spread of infectious disease.  The host is defined as the susceptible 
population to a particular disease causing pathogen or agent.  Agents can be altered and 
concentrated from their natural form to make the host more susceptible or to overcome 
the host resistance. Particularly virulent strains of Marburg virus and VEE were selected 
in the Soviet biological weapons program for these purposes (Alibek, 1999).  Use of the 
HAE framework might also include strengthening the resistance of a host through 
immunization.  The environment portion of the HAE model is defined as the medium that 
the agent can be transferred from host to host, typically through a vector or fomite.  
Chlorination of water supplies to create unsuitable conditions for waterborne agents is a 
method in which the environmental portion of the HAE framework is used.  Quarantine 
and isolation can also be used in the context of the HAE model by restricting the infected 
host from an environment where infection of other susceptible hosts could occur.  
Another important disease model in understanding the behavior of infectious disease is 
the Natural History of Disease, which divides all infectious disease into two basic phases: 
prepathogenesis and pathogenesis.  The prepathogenesis period begins with the agent in 
its environment and before a host is exposed.  The prepathogenesis period continues after 
exposure during a period where the agent is adapting to the host.  In this phase, infection 
can be prevented as the host’s immune response may prevent the agent from fully 
adapting to the host.  Once the host is infected, the pathogenesis period begins. 
Symptoms do not appear at first during latency or incubation.  The early portion of the 
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pathogenesis period is very critical in preventing the spread of disease since the infected 
host shows no appearance of infection, but can often introduce the agent to new hosts.  
Once infected hosts are identified or infectious pathways in the environment are known, 
methods can be devised to isolate the infected hosts or prevent the interaction between 
susceptible hosts and disease pathways in the environment.  If conducted properly these 
quarantine and isolation procedures are shown to be very effective.  Meltzer et al. 
modeled potential response strategies to a release of smallpox as a biowarfare agent. 
Quarantine and isolation was shown to be capable of eliminating an outbreak of 
smallpox.  The authors assumed that 50 percent of an infected population could be 
isolated starting 30 days after agent release and projected that by 240 days post release no 
new cases would occur (Meltzer, Damon, LeDuc, & Millar, 2001).  To ensure effective 
isolation, the infectious agent must be unable to transfer from infected hosts to a 
susceptible population outside of the isolation areas.  Effective levels of isolation and 
quarantine can be particularly difficult for airborne agents that can be quickly spread on 
aerosolized droplets or particles.  The use of an aerosolized viral agent in biowarfare 
could drastically increase the complexity of protecting potential hosts since the viral 
agent would be widely disseminated prior to the initiation of a response.  Determining the 
size of a cordon or initial quarantine area would be a necessary step in initial response to 
such an incident.  This step could be accomplished with an effective air sampling 
methodology.   
 
Direct environmental controls have also been proposed for localized outbreaks of viral 
disease.  The Air Force has proposed using ultraviolet radiation inside the ventilation 
 
5 
systems in high risk areas at Lackland AFB to control the airborne dissemination of 
Adenovirus.  However; there is no field deployable sampling methodology available for 
viruses that would be able to determine if these controls would be effective or necessary.   
Quarantine, isolation, protective equipment, and environmental controls must be able to 
reduce host exposure to a level that is below the infectious dose for a specific viral agent.  
This infectious dose varies according to the agent in question and the route by which 
exposure occurs.  To be effective, a sampling method for viral aerosols must be capable 
of detection at levels at or below the minimum infectious dose.   
 
Biological Sampling and Detection Equipment 
A wide range of equipment is marketed for the detection and quantification of biological 
aerosols.  Much of this equipment is also advertised as being capable of collecting 
airborne viruses.  Collection methods and devices for the sampling of viral aerosols can 
be broadly grouped into two categories: high volume and low volume.  High volume 
methods typically collect air samples at rates of over 40 liters per minute, and some are 
capable of sampling rates of up to 1,000 liters per minute.  Because of the low airborne 
concentrations expected in an outdoor environment, air sampling devices intended for use 
in response to biological warfare agents are almost exclusively high volume.  The quick 
collection of a large volume of sample allows for fast confirmatory analysis for 
immediate response personnel.  Low volume devices operate at airflows below 40 liters 
per minute and are more frequently used in laboratory or field experimental analysis 
where collection and quantification of aerosolized biological specimens is necessary.  
Sampling devices for bioaerosols can also be grouped by their means of collection.  
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These broad categories include liquid impaction, solid impaction, and filter collection 
(Verreault, Moineau, & Duchaine, 2008).   
Solid impaction methods include Andersen samplers, slit samplers (slit to agar samplers 
are an example), and cyclone samplers.  While the efficiency of solid impaction samplers 
is typically higher for larger particles; some, such as the Andersen sampler, can be used 
for particle sizes as small as 0.65 micrometers (Verreault, Moineau, & Duchaine, 2008).  
Some solid impaction samplers also provide additional capabilities not available for 
liquid or filter collection, such as particle sizing (Andersen sampler) and time resolution 
(Slit to agar).  Illustrations of these solid impaction devices are shown in Figure 1. 
  
 
 
Figure 1: Solid Impaction Aerosol Collection 
 (Verreault, 2008. Reproduced with Permission from American Society of Microbiology)  
 
 
 
Liquid collection methods have been used for bioaerosol collection since the 1950’s, and 
involve the use of an impinger to capture viruses. Impingers are the most commonly used 
type of sampler in the collection of airborne viruses.  Classic impinger systems such as 
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the All Glass Impinger (AGI) place an airflow exit at a set distance of 4 mm for the AGI-
4 and 30 mm for the AGI-30 from the bottom of a fluid vessel.  This placement creates a 
sharp turn in the streamline of the airflow that traps particles in the collection fluid.   
More recently, a new form of liquid impinger, the swirling aerosol collector, came into 
use for the collection of viral aerosols.  The swirling aerosol collector is expected to 
retain more viability in the collected sample than other impinger methods.  This impinger 
is manufactured by SKC, Inc. and marketed under the trade name Biosampler.  An 
illustration comparing the swirling aerosol collector with a conventional impinger, the 
AGI-30 is shown in Figure 2. 
 
 
 
Figure 2: Liquid Impinger Models 
 (Verreault, 2008. Reproduced with Permission from American Society of Microbiology) 
 
 
Filter aerosol collection is often more efficient than other sampling methodologies for 
collecting small particles with aerodynamic sizes less than 500 nanometers (Verreault, 
Moineau, & Duchaine, 2008).  However; filter collection presents several limitations for 
their use in sampling for airborne viruses.  Filters are known to cause structural damage 
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to the collected virus and desiccate the sample, thus reducing the amount of viable virus 
available for culture analysis (Verreault, Moineau, & Duchaine, 2008).  Additionally, the 
use of filters for collection can pose difficulties in sample analysis.  Many sample 
analysis methodologies require a liquid medium; therefore, the sample must be extracted 
from the filter into the liquid media.  The tendency of the filter to retain the sample (Cox 
& Wathes, 1995) can increase the challenges of this extraction.  This extraction process 
could significantly reduce the amount of sample available for analysis. 
 
Air sampling for biological agent identification exclusively employs high volume air 
sampling equipment.  This requirement for high volume sampling equipment is driven by 
the relatively low air concentrations expected in a response area and the need for fast 
collection of a sufficient quantity of sample for analysis.  Many low volume systems, 
such as those described above, have been evaluated for collection of viral aerosols in a 
wide range of studies.  So far, most high volume systems have not been evaluated for 
effectiveness in the collection of viral aerosols.  This lack of evaluated effectiveness 
creates a major obstacle to the reliable and confident use of these systems in response to 
an aerosolized viral agent.    
 
Air Force Use of Biological Sampling Equipment 
The United States Air Force has employed biological agent detection at high risk sites for 
over 10 years.  This capability is still in place with the Air Force use of the Portal Shield 
monitoring system.  The Portal Shield, deployed in high risk areas throughout the world, 
provides continuous agent monitoring at a fixed site.  In the period immediately 
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following the attacks on September 11, 2001, and the anthrax letter incidents in 
September and October 2001, the Air Force scrambled to acquire air sampling equipment 
capable of mobile response to an incident involving biological weapons.  The two 
systems purchased by the Air Force for this purpose included the XMX/2-MIL, 
manufactured by Dycor Technologies, Inc., and the DFU-1000 manufactured by 
Lockheed Martin Integrated Technologies.  The XMX was selected by the 
Bioenvironmental Engineering community as their primary field portable sample method 
for viral aerosols, while Civil Engineering Emergency Management personnel selected 
the DFU-1000.  These two instruments were purchased with the intent of responding to 
an incident involving biological weapons. Very little investigation was made into other 
potential uses, capabilities, or limitations associated with these samplers.  Organizations 
outside of the Air Force have used the XMX/2L-MIL and DFU-1000 for purposes other 
than biological warfare response with varying degrees of success.  This expanded use 
prompted the United States Air Force School of Aerospace Medicine (USAFSAM) to 
consider the using the XMX/2L-MIL and DFU-1000 to monitor for adenovirus and for 
other responses involving other viral agents.     
 
The XMX/2-MIL is a multiple stage collection method that pairs virtual impaction with 
liquid impingement.  Virtual impaction differs from conventional aerosol impaction in 
that conventional impaction removes particles below a certain cutoff size, while virtual 
impaction separates a single airflow stream into two airflows that are differentiated by 
particle size.  After passing through virtual impaction, airflow is divided into major and 
minor flow streams. The major flow stream primarily contains particles smaller than a 
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certain cutoff size, while the minor flow stream primarily contains particles larger than 
the cutoff size (Loo & Cork, 1988).  The XMX/2L-MIL uses multiple virtual impaction 
stages to concentrate a high volume of airflow into a low volume airflow consisting 
primarily of particles in the respirable size range of 1 to 10 micrometers.  The flow rate 
entering the XMX is greater than 500 liters per minute, but is reduced into a secondary 
flow of approximately 12.5 liters per minute.  This concentrated secondary flow is then 
transferred via a liquid impinger into a collection media.  Typically sterile water, 
phosphate buffered saline, or a user specified collection media, such as Remel M5, is 
used for this final sample collection step.  
 
The DFU-1000 is a high volume air sampler that employs filter collection as an aerosol 
collection mechanism.  The DFU-1000 is capable of sampling for long periods of time at 
high rates of airflow up to 800 liters per minute.  The DFU-1000 utilizes a standard 47 
millimeter diameter polyester felt filter with a 1.0 micrometer pore size.  This filter has 
been evaluated for particle sizes as low as 100 nanometers and was shown to have a 75 
percent collection efficiency for particle sizes of 100 nanometers (Lawrence, 2003).  The 
DFU-1000 is intended for indoor air sampling only however an updated version, the 
DFU-2000, was developed to allow outdoor sampling.  The DFU-2000 is a DFU-1000 
with  a protective housing, a mast extending up to 3 meters in height, and a pre-separator 
to remove large particles or debris.  These modifications allow for the DFU-2000 to 
sample in harsh ambient conditions (JPEO-CBDX, 2008).  
 
 
11 
While the XMX/2-MIL and DFU-1000 are widely deployed at most domestic and 
overseas Air Force bases, most bases typically maintain only one or two of each system.  
For this reason, the ability to use these devices multiple times at multiple sample 
collection points is critical and multiple use capability is a major comparison criteria.  In 
order to provide this capability, the collection system used must be capable of 
decontamination under field operating conditions.  No study employing infectious viral 
agent has been published to determine if either the XMX/2-MIL or DFU-1000 is able to 
be decontaminated in the field after exposure to a viral agent.     
 
Biological Analysis Methods 
Analysis methods for viral samples include plaque assay and polymerase chain reaction 
(PCR) analysis.  Plaque assay was originally developed for the measurement of 
bacteriophage stock, but has since been applied to the study of mammalian virus (Adams, 
1959).  Plaque assays function by culturing a virus sample on a plate consisting of cell 
nutrient agar and cells that are susceptible to infection.  The cell material utilized depends 
on the virus for which the analysis is intended.  The plaque assay method provides a 
quantitative measure of viable infectious virus present in a sample.  However; several 
limitations prevent plaque analysis from being used as the preferred analysis method for 
biological response to a viral agent.  These limitations include the time lapse required to 
culture the plates and the availability of infectious virus to perform analysis.  In order to 
use plaque assay as a primary or confirmatory analysis method, recovery of viable viruses 
from an aerosol collector is required.  These limitations severely restrict the use of plaque 
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assay in a biological agent response.  Nevertheless, plaque assays can still be effective for 
confirmation analysis when a positive test result is obtained using other methods.  
 
PCR analysis provides a solution to the limitations presented by plaque assay.  PCR 
allows for the detection of viral DNA, and functions by replicating a small amount of 
DNA in a sample to make multiple copies which then allows for detection to occur.  This 
technique requires the addition of “short DNA strands called primers to target specific 
sequences in sample DNA” (Ty, 2007).  The addition of the primers often requires that 
some sequence of the sample DNA be known (Bermingham & Luettich, 2003).  This 
limits the use of PCR to applications where a specific agent or group of specific agents is 
suspected.  The Air Force employs the Joint Biological Agent Identification and 
Diagnostic System (JBAIDS) to provide PCR analysis capability to its Laboratory 
Response Teams (LRT).  JBAIDS is manufactured by Idaho Technology Incorporated, 
and is capable of identifying 10 known biological agents.  Results can be provided in a 
period of 40 minutes (Wilson, 2006).  The primary limitation of PCR is that it detects 
only the viral DNA or RNA present rather than the infectivity of the virus.  Therefore; 
PCR cannot distinguish between deactivated virus and infectious virus.  This limitation 
makes PCR analysis unsuitable to evaluate the effectiveness of environmental controls 
for viral aerosols such as those proposed for the control of adenovirus.   
 
Laboratory Evaluation of Sampling Methodologies 
Most laboratory studies for airborne viruses are conducted using an exposure chamber.  
The use of an exposure chamber for initial evaluation of viral aerosol collection methods 
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allows for the study of aerosols under controlled atmospheric conditions for extended 
periods and over multiple trials.  The use of an exposure chamber also allows the aerosol 
to be continuously mixed and prevents the gravitational settling of particles during a trial 
(Verreault, Moineau, & Duchaine, 2008). These laboratory evaluations can then be 
followed with field testing in order to comprehensively evaluate a sampling methodology 
under less controlled conditions.    
 
Thesis Objectives and Limitations     
This study seeks to determine if the XMX/2-MIL and DFU-1000 meet the criteria 
required for their use in response to the malicious release of a viral agent or during an 
outbreak of a viral disease.  These criteria include recovery of viable virus, limits of 
detection or quantification, and field decontamination.  These sampling systems will be 
evaluated simultaneously and compared based on these criteria.  This will provide 
information to responders in selecting the equipment and sampling methods to conduct 
air sampling for viral agents.  This study will be limited to evaluating the XMX/2-MIL 
and DFU-1000 only.  Other high volume air sampling devices are not widely available to 
Air Force personnel.  The XMX/2L-MIL and DFU-1000 will be evaluated in a laboratory 
exposure chamber.  Field testing will not be conducted as part of this project.  This study 
will test the XMX/2L-MIL and DFU-1000 using a single sample duration and collection 
media.  While the use of different sample durations and collection media could affect the 
performance of the equipment, time and resources did not allow these parameters to be 
evaluated in this study.  Ambient factors during sampling were not varied during 
analysis.  Ambient factors such as temperature and humidity have been widely studied in 
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previous viral studies and found to have significant impact on the infectivity of viruses 
(Verreault, Moineau, & Duchaine, 2008).  Further laboratory studies and field testing will 
be necessary to fully evaluate the effectiveness of these sampling methodologies under all 
conditions.   In the decontamination portion of this study, only field decontamination was 
evaluated.  Laboratory grade decontamination such as autoclaving or heat sterilization is 
likely to be more effective.  In practice, these laboratory grade methodologies are 
unlikely to be available for field use in a response.  Analysis was limited to quantification 
by viral plaque assay with presence/absence analysis using the JBAIDS.   Quantitative 
and semi-quantitative PCR analysis was not performed as part of this study.  These 
quantitative PCR methods are unavailable to Air Force LRTs for analysis of samples 
collected from the XMX/2L-MIL and DFU-1000 in response to a biological agent, and 
would not be representative of Air Force field capabilities.         
 
The Air Force does not typically evaluate biological sampling equipment acquired from 
commercially available sources.  Information is provided by the manufacturer and 
evaluated by the organization considering the purchase.  This acquisition method is 
classified as commercial off the shelf (COTS) (Wilson, 2006).  While this process is 
considerably faster and less involved than other acquisition processes, it fails to fully 
assess the capabilities and limitations of the equipment.  Furthermore, the Air Force is 
reliant on the accuracy of manufacturer information.  This introduces the potential for 
biased or incomplete information to be used during purchasing and equipment 
application.  This study provides a limited, independent evaluation of two biological 
sampling systems and should provide insights on the effectiveness of using Air Force 
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resources to independently evaluate future biological equipment acquisitions and 
deployment applications of existing equipment.       
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II. Literature Review 
 
Overview 
This section seeks to review scientific literature pertinent to sampling for aerosolized 
viral agents. Many focus areas are presented including historical studies on viral agents of 
interest, factors related to aerosol particle size, external factors that affect sampling, use 
of viral surrogates, previous studies involving high and low volume viral air sampling, 
and decontamination of sampling equipment.  Studies conducted both in the field and in 
laboratory environments will be reviewed.  Currently, Air Force biological air sampling 
equipment employs dry filtration, virtual impaction, and collection by liquid impinger.  
This review will provide more emphasis on these sample collection methods, and on 
factors influencing their use.  The literature reviewed will further the objective of 
applying laboratory methods to comparatively evaluate operational equipment for the 
sampling of viral aerosols.  The literature review for decontamination methods will focus 
on hypochlorite solution use for decontamination, and emphasize studies previously 
conducted by USAFSAM.  
 
Air Sampling Background 
Air sampling is a critical component of an evaluation to support making a health risk 
assessment following the release of a biological, radiological, or chemical agent.  Air 
sampling is the primary method to determine the “nature, concentration, and 
pathogenesis” of airborne microorganisms (Verreault, Moineau, & Duchaine, 2008).  
However; the science of air sampling for viruses is developing, particularly with regard to 
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the use of high volume air sampling methods.  Numerous studies have been conducted on 
a variety of sampling methodologies and analytical techniques resulting in the 
identification of many “advantages and pitfalls” (Verreault, Moineau, & Duchaine, 
2008).  Detection and quantification of an airborne virus “is dependent on three primary 
factors: the concentration of airborne virus, the collection efficiency of the air sampling 
system, and the analytical sensitivity of the diagnostic assay” (Hermann, Hoff, Yoon, 
Burkhardt, Evans, & Zimmerman, 2006).  Unfortunately, many of these techniques have 
not been fully explored for many viral agents of interest or for high volume air samplers 
currently in operational use by the Air Force.  Due to the limited breadth and depth of 
work on the subject of air sampling for viruses, “there are currently no standard methods 
for the recovery and detection of specific pathogens…  The lack of guidance requires that 
sampling methods be optimized and validated for each target pathogen. (Hermann, Hoff, 
Yoon, Burkhardt, Evans, & Zimmerman, 2006).  Such optimization and validation is 
necessary for all pathogens of interest, including viral agents, and for all sampling 
equipment currently in the Air Force inventory, including the XMX/2L-MIL and the 
DFU-1000.         
  
Historical Studies of Interest 
Air Sampling for Variola 
Disease researchers have attempted air sampling in cases involving airborne viruses for 
over 60 years.  Most of these early attempts involved sampling in areas where airborne 
viruses were considered likely to be found, such as in the immediate vicinity of a patient 
confirmed to have a viral disease.  Two early studies with implications in the study of 
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biological warfare agent sampling involved air sampling at a smallpox hospital in 
Madras, India.  These studies, conducted in 1960 and 1963, involved air sampling in 
close proximity to smallpox patients at various stages of disease progression and at 
various points throughout the hospital and patient wards.  The 1960 study, conducted by 
Meiklejohn et al., involved the collection of 38 separate air samples collected using a 
crude filter consisting of a glass tube packed with dry cotton.  Sample analysis was 
conducted by inoculating chicken embryos with the collected sample.  This analysis 
method allowed for the detection and crude quantification of infectious virus (in pock 
forming units), assuming the presence of sufficient quantities.  Both the air sample 
collection and analysis methods had been tested experimentally in a laboratory 
environment and shown to be effective for the detection of aerosolized vaccinia 
(Meiklejohn, Kempe, Downie, Berge, St. Vincent, & Rao, 1961).  Laboratory studies 
indicated that liquid impinger collection were four times more efficient in the collection 
of virus than using dry cotton.  Aggressive sampling techniques were used in many of the 
air samples, such as locating the sampler 12 inches from the mouth of an acutely ill 
patient and sweeping scabs directly underneath the sample collection point (Meiklejohn, 
Kempe, Downie, Berge, St. Vincent, & Rao, 1961).  Despite these aggressive techniques, 
variola recovery from air samples was relatively ineffective.  In the 1960 study, only one 
sample of the 38 collected produced a positive result for variola and even then in small 
quantities (Meiklejohn, Kempe, Downie, Berge, St. Vincent, & Rao, 1961).  The 1963 
study used an all glass impinger with liquid collection media instead of a dry filter, but 
was only modestly more successful.  Ten impinger samples out of 52 collected resulted in 
the detection of Variola major (Downie, Meiklejohn, St. Vincent, Rao, Sundara Babu, & 
 
19 
Kempe, 1965).  The overall low level of detection in the air samples was attributed to the 
lack of sensitivity of the sampling methodology and potentially due to environmental 
conditions, such as rapid air dilution in the hospital.  Variola recovery from surface swabs 
on pillows, bed sheets, and from settling plates was more effective with a majority of 
these samples yielding infectious variola.  These results indicate that swabbing can be an 
effective recovery technique for the detection of viral contamination.  Additionally, 
swabbing could also allow for the quantification of virus containing particles that have 
settled from the air.   
 
Air Sampling for Adenoviruses 
Air sampling was also attempted for adenovirus in 1967.  This study, conducted by 
Artenstein et al. on military patients with confirmed adenovirus infections, used a high 
volume electrostatic precipitator with a cyclonic pre-impactor system capable of 
sampling approximately 10,100 liters per minute (Artenstein, Miller, Lamson, & Brandt, 
1968).  Similar to the smallpox studies, Artenstein et al. used aggressive sampling 
techniques in this study.  Aggressive techniques included having an infected patient 
cough directly over the sampling orifice and having the patient stand in a room and cough 
frequently for 5 minutes while the air sampler was running.  Of the four adenovirus 
sample runs, three produced viable virus. This study can be applied to the Air Force 
requirement for a system capable of sampling for viable adenovirus because it 
demonstrates that in sufficient concentrations, environmental recovery of viable 
adenovirus from an air sample is possible. 
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Implications of Historical Studies to Modern Air Sampling Equipment 
Many of the modern high volume air sampling systems for bioaerosols employ collection 
methods similar to those found in the historical studies.  For example, wet-walled 
cyclones are used in high volume systems to collect respirable bioaerosol particles.   Wet- 
walled cyclone collection has many similarities to the pre-impactor used by Artenstein 
eliminate large, irrespirable, particles from final sample collection.  Furthermore, many 
of the sampling methods used in the smallpox field studies form the basis for much of the 
biological air sampling equipment used today.  For example, the dry cotton packed tubes 
used by Meiklejohn to collect samples for smallpox are a crude dry-filter sampling 
system similar in principle to the current DFU-1000 used by the Air Force.  These early 
studies demonstrate that the recovery of viable airborne virus is possible provided the 
concentration of virus present is sufficient.  Some limitations of these early studies have 
been addressed today.  For example, sample analysis methods for both the smallpox 
studies and the adenovirus studies required infectious virus to be recovered by the air 
sampling method.  Detection techniques for viral DNA and RNA such as polymerase 
chain reaction (PCR) were unavailable in the 1960’s and do not require infectious virus 
for detection.  The smallpox studies also demonstrate the difficulties in applying 
sampling techniques to field studies even when the sampling techniques are found 
effective in a laboratory setting.  Many of these difficulties persist in field applications of 
sampling methodologies today.  Studies on smallpox could not be repeated today since 
research on active variola is strictly controlled.  Therefore these studies provide the only 
direct information available on air sampling for this important viral agent.  Probably the 
most important observation of the air sampling studies for smallpox was the effectiveness 
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of liquid collection compared to dry filter collection.  The liquid impinger collected 
viable smallpox virus in 12 out of 52 samples (Downie, Meiklejohn, St. Vincent, Rao, 
Sundara Babu, & Kempe, 1965), while the dry filter method collected viable smallpox 
virus in only 1 out of 38 samples (Meiklejohn, Kempe, Downie, Berge, St. Vincent, & 
Rao, 1961).  This disparity suggests that liquid collection for some viral agents could be 
more effective than dry collection methods.  The limited detection of virus in both of 
these smallpox studies also reveals the difficulties in conducting air sampling for Variola, 
and the relatively high airborne concentrations of viable virus required to generate a 
detectable, much less quantifiable, result.  These details underscore the need for 
biological air sampling systems to be robustly evaluated for their effectiveness in the 
collection of viral agents.  This need should extend to the sampling equipment currently 
used by the Air Force as well. 
 
Particle Characteristics and Viral Aerosols 
Particle size has been shown to be one of the most important characteristics related to the 
airborne residence time of the viral aerosol, its potential for infection, and the efficiency 
at which the virus can be recovered during sampling.  Therefore the particle size of an 
aerosol containing a biological agent must be fully considered in both laboratory and 
field evaluation of sampling equipment. 
 
Health Assessment Considerations Regarding Particle Size on Air Sample Collection 
The health impact of aerosolized particles “is size dependent”, and measurement of 
particle size distribution should be included in field studies and “controlled in laboratory 
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studies of virus particles” (Hogan, Kettleson, Lee, Bamaswami, Angenent, & Biswas, 
2005).  The nose and upper airways prevent airborne particles greater than 10 
micrometers from entering the respiratory system.  For this reason, most air sampling 
equipment for bioaerosols strip out particles larger than this 10 micrometer cutoff.  The 
study of aerosolized biological agents has largely centered on particle sizes in the 
“respirable” size range of less than 10 micrometers to provide a proper representation of 
human exposure.  Less is known or understood at the submicrometer end of the particle 
size distribution.  Submicrometer sized particles likely play a larger role in morbidity 
than previously considered (Hogan, Kettleson, Lee, Bamaswami, Angenent, & Biswas, 
2005), and are not efficiently collected by most high volume air sampling equipment.  
The respiratory deposition probability of various particle sizes is shown in Figure 3.  It is 
important to note that even a 0.3 micrometer sized particle has a 15 percent probability of 
deposition in the human respiratory tract (Maynard & Kuempel, 2005).  For this reason, 
air sampling equipment for viral agents should be able to include a reasonable collection 
efficiency of submicrometer particles to better characterize human exposure to a viral 
aerosol.  Preferably, the collection efficiency for submicrometer particles would be at 
least equal to the deposition probability in the respiratory tract.   
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Figure 3: Respiratory Deposition Probability 
(From Maynard & Kuempel, 2005.  Reprinted with kind permission from Springer Science) 
 
Air Sampling and Particle Size Considerations 
Development of biological detection equipment has centered on the ability of the 
equipment to limit air sampling to the respirable size range.  This includes the equipment 
currently inventoried by the Air Force.    The XMX/2L-MIL limits sample collection 
primarily to the 1 to 10 micron size range (Tucker, 2005), and has very limited collection 
effectiveness in the collection of submicrometer particles.  Specific information on the 
collection efficiencies of the XMX/2L-MIL is available through USAFSAM.   The DFU-
1000 is a filter collection system and collects particles above the minimum collection size  
of the filter.  However, particle collection can extend to particle size ranges significantly 
below the pore size of the filter.  The standard filter provided with the DFU-1000 is a 
polyester felt filter with a 1 micron pore size and has a reported efficiency of 
approximately 75 percent for 100 nanometer sized particles (Lawrence, 2003).  Although  
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it is unclear if these efficiencies reported by Lawrence consider the high velocity air flow 
conditions produced across the filter by the DFU-1000 during sample collection.  
Regardless, high efficiencies would not be unexpected for the collection of 
submicrometer sized particles.  Filters are commonly used in the sampling of fine viral 
particles, particularly for particle sizes less than 500 nanometers (Verreault, Moineau, & 
Duchaine, 2008).  Additionally, low volume liquid impinger sampling systems have also 
been evaluated for their collection efficiency of micrometer and submicrometer particles, 
including the AGI-30 and the Biosampler.  The reported collection efficiencies for these 
systems are included in Table 1. 
 
 
Particle Size 
(Microns) AGI-30 Collection Efficiency (%) 
Biosampler Collection Efficiency 
(%) 
0.3 69 78 
0.6 71 88 
0.8 72 91 
1.1 82 92 
1.7 93 93 
2.0 95 95 
 
Table 1: Particle Collection Efficiency of AGI-30 and Biosampler From Willeke et al., 1998 
  
 
Particle Composition of Viral Aerosols    
Virus containing particles consist of a variety of constituents, much of which is inorganic 
(Verreault, Moineau, & Duchaine, 2008).  For this reason, the virus accounts for very 
little of the agent containing particle and a negligible portion of the aerosol.  Also, the 
addition of virus to experimental aerosols has little impact on the size characteristics of 
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the aerosol when compared to the suspension media or the method used to generate the 
aerosol (Hogan, Kettleson, Lee, Bamaswami, Angenent, & Biswas, 2005).  Free viruses 
are uncommon in the environment since particles tend to form aggregates very rapidly 
when airborne (Verreault, Moineau, & Duchaine, 2008).  This tendency, along with the 
binding of virus within droplets and particles, allows for the air sampling of virus 
particles without the need to collect the ultrafine individual virons.  The importance of 
submicrometer sized viral particles in natural viral aerosols is not well understood, but is 
likely to have a strong affect on the health risks relating to human exposure.  
Furthermore, the majority of airborne virus containing particles may be submicrometer 
sized (Hogan, Kettleson, Lee, Bamaswami, Angenent, & Biswas, 2005).  Hogan’s 
observation has been verified in other viral particle studies as well.   In a study of exhaled 
influenza virus particle sizes conducted by Fabian et al. on patients infected with 
influenza A and B, approximately 70 percent of particles in exhaled air were less than 0.5 
micrometers in size and 87 percent were less than 1 micrometer in size.  Exhaled 
influenza containing particles greater than 5 micrometers were very rarely observed.  
Fabian’s study indicates that fine particles of less than 1 micrometer may be a major 
contributor in disease transmission for influenza (Fabian, et al., 2008).  Studies on other 
viral diseases have yielded different particle size information.  For example, livestock 
viruses such as Foot and Mouth virus and Aujeszky’s disease virus were mostly 
contained in particles greater than 3 micrometers in size (Verreault, Moineau, & 
Duchaine, 2008).  Particle or droplet size may significantly impact the airborne viability 
of virus in a aerosol.  As shown in Figure 4, the droplet nucleus, including the viruses in 
an aerosol droplet, become more exposed to environmental factors as the droplet dries 
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out.  The final size of the droplet nucleus may also be directly related to the relative 
humidity.  This is particularly true in the study of artificially produced viral aerosols in an 
exposure chamber. 
 
 
  
Figure 4: Droplet Evaporation in a Viral Aerosol 
From Verreault et al., 2008.  Reproduced with permission from the American Society of 
Microbiology. 
 
 
Artificially produced aerosols, such as those used in controlled chamber studies, are not 
studied in the presence of other aerosols that may be present in a natural environment.  
This condition prevents “binding of the nebulized particles”, and allows particle size to 
be “influenced only by the size of the droplet created by the nebulizer and the solute 
concentration” (Verreault, Moineau, & Duchaine, 2008), which may not represent 
behavior in a natural environment.  This factor may limit field use of aerosol collection 
data gathered in the laboratory chamber setting.  For this reason, air sampling studies 
conducted in a chamber environment should consider these limitations before applying 
laboratory generated data for field use.  This limitation should be applied to laboratory 
evaluation of Air Force high volume air sampling equipment as well. 
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Particle Size and Settling Characteristics 
The particle size of a viral aerosol is the key parameter in determining the settling rate 
and, consequentially, their duration in the airborne environment.  Particle sizes of 100 
micrometers settle from a drop height of 8 feet in approximately 8 seconds, while 1 
micrometer particles require 19 hours to settle.  Submicrometer sized particles can remain 
airborne for several months or longer (Utrup & Frey, 2004).  The slow settling 
characteristics of 1 micrometer and smaller particles allows for airborne exposure to 
occur long after the aerosol is disseminated in an area.  This feature also allows aerosols 
comprised of submicrometer particles to be carried for longer distances after 
dissemination and leads to larger areas of exposure risk.  Dilution and environmental 
degradation of the aerosol may reduce these health risks; nonetheless, a high volume air 
sampler would need to collect a reasonable fraction of these micrometer and 
submicrometer sized particles in order to fully assess health risk.      
 
Measurement of Particle Size Distribution of Viral Aerosols 
A variety of equipment is available to measure particle size during aerosol studies, 
including real time measurement devices such as particle spectrometers and gravimetric 
devices such as cascade impactors.  Cascade impactors use a series of impaction stages 
with descending particle size cutoff points.  The cutoff size points are “determined by the 
velocity of air through the nozzle and the distance of the nozzle from the collection 
surface” (Cox & Wathes, 1995).  These cascade impactors pre-date the real time 
methodologies and are typically used as the “gold standard” in the development of real 
time methods.  An evaluated method is the aerodynamic particle sizer (APS) 
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manufactured by TSI.  The APS measures particle size by “determining the time-of-flight 
of individual particles in an accelerating flow field” and is capable of measuring particle 
size distributions in a particle size range of 0.5 microns to 20 microns (Peters & Leith, 
2003). The APS, model 3321, was evaluated by Peters and Leith for collection efficiency 
over a range of particle sizes from 1 micron to 4 microns.  These efficiency evaluations 
were conducted by comparing particle mass data obtained from the APS with the results 
of particle collection using a cascade impactor.  Counting efficiency for particle size 
ranges of 1 to 3 microns was approximately 45% for the TSI 3321 and approximately 
60% for particles in the 4 micron size range.  Despite these lower overall counting 
efficiencies, the particle size distribution produced by the TSI 3321 was similar to the 
size distribution generated using data from a cascade impactor.  This is primarily due to 
the relatively consistent efficiency over the range of particle sizes evaluated (Peters & 
Leith, 2003).  This study demonstrates that the APS data can be used to determine a 
particle size distribution, but data on total particle load likely requires adjustment.  
Another commonly used instrument for particle size analysis is the Grimm Technologies 
portable aerosol spectrometer (PAS) model 1.108.  The PAS divides a particle size 
distribution into 16 size channels, while the APS divides the particle size distribution into 
52 size channels (Peters, Ott, & O'Shaughnessy, 2006).  Both the PAS and APS can count 
particles as large as 20 microns.  One key advantage of using the PAS for particle size 
analysis in the study of a viral aerosol is that the Grimm provides particle size 
distribution data for particles as small as 0.3 microns. The APS distribution data has a 
lower particle size counting limit of 0.5 microns (Peters, Ott, & O'Shaughnessy, 2006). 
The accurate measurement of the particle size distribution is essential in the laboratory 
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evaluation of air sampling equipment.  These measurements ensure that artificially 
generated aerosols used in a chamber sufficiently represent particle sizes that may be 
present in the environment.  The evaluation of Air Force high volume air sampling 
equipment should incorporate particle size measurements that are as accurate as possible 
for both micrometer and submicrometer particles.    
 
External Factors on the Collection of Viral Aerosols 
Many environmental factors can impact the behavior and sampling characteristics of 
aerosolized viruses.  Factors that are particularly important to the behavior of aerosolized 
virus include relative humidity and temperature.  Levels of ultraviolet radiation can 
significantly impact the viability of aerosolized viruses in an outdoor environment.  As 
discussed earlier, the particle size and composition of a virus containing droplet can be 
greatly affected by the relative humidity (Verreault, Moineau, & Duchaine, 2008).  This 
allows the size of particles in a chamber to be increased or decreased through the 
adjustment of relative humidity.  Many viruses also exhibit different infectivity 
characteristics as the relative humidity is changed, which will be discussed further in the 
surrogate viruses section.  “The stability of certain infectious airborne viruses” is also 
influenced by temperature, with certain viruses exhibiting greater infectivity at lower 
temperatures (Verreault, Moineau, & Duchaine, 2008).  This effect on virus stability was 
shown to be minimal for certain bacteriophages, such as MS2, when aerosols were 
generated using tyrptone broth instead of salt solution (Dubovi & Akers, 1970).  For 
these reasons, proper control of environmental conditions must be maintained in air 
chamber studies during the evaluation of Air Force air sampling equipment.  
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Furthermore, the impact of relative humidity on viral stability could be minimized by 
impropriating tyrptone broth in the aerosol solution.     
 
Infectious Concentration of Viral Aerosols 
There is a dearth of published information available on the minimum aerosol 
concentration required to produce an infection with viral agents of interest.  One study 
conducted by the United States Army Medical Research Institute of Infectious Diseases 
(USAMRIID) exposed non-human primates to an aerosol of Ebola-Zaire, a CDC 
category A agent.  Two rhesus monkeys were exposed to a 400 PFU aerosol dose of 
Ebola-Zaire.  Both monkeys died or were euthanized after morbidity was observed 
(Leffel & Reed, 2004).  Although these lethal viral exposure levels would apply only to 
an aerosol containing Ebola-Zaire, aerosol studies attempting to evaluate a limit of 
detection for high volume air sampling equipment should attempt to achieve viral 
concentrations below the lethal doses used in the Leffel study.   
 
Viral Surrogates 
The evaluation of air sampling methodologies for viral agents requires the aerosolization 
of infectious virus.  Since these agents can be very pathogenic to humans and capable of 
airborne transmission, any study aerosolizing active pathogen typically requires operating 
under bio-safety level (BSL) three or four.  According to the American Biological Safety 
Association, Smallpox and Marburg both require a BSL 4 level laboratory, while any 
studies using VEE require a BSL 3 lab (ABSA, 2004).   Providing this level of 
protection, in addition to purchasing the agent itself, is very resource intensive and 
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impractical under most circumstances (Foarde, Hanley, Ensor, & Peter, 1999).  To 
overcome these limitations, many studies use a surrogate virus to simulate a pathogenic 
virus with similar characteristics.   
 
Viral Surrogate Use in Previous Studies 
Bacteriophages are often used as viral surrogates, including male specific 2 (MS2) and 
T3 bacteriophage.  Bacteriophages, as their name implies, use bacteria as their only host 
organism, and represent no risk to humans, providing that the host bacteria are not 
pathogens.  MS2 has been used in studies to represent a variety of viral agents.  Langlois 
used MS2 as a surrogate for smallpox virus in the development of field deployable 
biological detection equipment (Langlois, 2002).  Another study by Foarde et al. used 
MS2 as a surrogate for a variety of similar viral agents, including retroviruses and pox 
viruses.  Foarde noted that bacteriophages have aerosol characteristics similar to many 
human viruses (Foarde, Hanley, Ensor, & Peter, 1999).  Like to agents of interest, viral 
surrogates can also be very persistent and hardy under experimental conditions.  Utrup 
and Frey used MS2 as a viral surrogate when they studied the fate of bioterrorism-
relevant organisms in an indoor environment.  Utrup and Frey observed that 52 percent of 
the MS2 aerosolized in an exposure chamber remained viable in an aerosol form during 
the 45 minute time frame of the study (Utrup & Frey, 2004).  These successful previous 
studies make bacteriophages a reasonably vetted and economical choice for the 
evaluation of high volume air sampling equipment by the Air Force.    
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Limitations to the Use of Viral Surrogates 
The use of viral surrogates has many limitations.  Hogan et al. observed that 
generalizations should not be made between different virus types and that viability during 
sampling can only be accurately determined when viruses are tested individually (Hogan, 
Kettleson, Lee, Bamaswami, Angenent, & Biswas, 2005).  Different viral types and 
subtypes exhibit a broad range of structures and composition of nucleic acids.  MS2, 
despite its common use as a surrogate, cannot accurately represent the behavior of all 
viral agents of interest (Tseng & Li, 2005).    Many studies have found that even viruses 
of similar size and shape exhibit different behavior in aerosolization and collection.    
Hogan et al. evaluated MS2 and T3 separately and found large differences in collection 
efficiency performance between sampling for MS2 and sampling for T3.  These 
differences were observed for all three sampling methodologies evaluated including the 
AGI-30 manufactured by Ace Glass Inc., the Biosampler swirling aerosol collector 
manufactured by SKC, Inc., and the Fritted Bubbler.  For example, the lower limit of 
virus collection after 30 minutes of sampling for the AGI-30 using MS2 was 
approximately 19 percent, while for T3 under the same conditions, the lower limit of 
virus collection was observed to be approximately 1 percent (Hogan, Kettleson, Lee, 
Bamaswami, Angenent, & Biswas, 2005).  Tseng and Li evaluated sampling 
characteristics for four different bacteriophages including MS2, Phi X174, Phi 6, and T7.  
These bacteriophages represented a broad range of nucleic acid structure including single 
strand RNA, single strand DNA, double strand RNA, and double strand DNA, 
respectively.  Viruses with a lipid envelope, such as Phi 6, are generally hydrophobic, 
while viruses without a lipid envelope such as MS2, Phi X174, and T7, exhibit 
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hydrophilic behaviors.  This condition is particularly important during sample collection 
since viruses with lipid envelopes are much more sensitive to stresses during sampling.  
Tseng and Li also found that viruses with tail fibers, such as T7, exhibit greater 
sensitivity to relative humidity than untailed viruses (Tseng & Li, 2005).  Their studies 
show that it is important to consider more than viral size and aerosol characteristics in the 
selection of a surrogate virus.  Surrogate virus selection should also consider the physical 
structure of the virus and the nucleic acid type and structure.  Similar to MS2, the 
Marburg virus is also a single strand RNA virus, although significantly larger than an 
MS2 bacteriophage (Elliott, McCormick, & Johnson, 1982).  Poliovirus, similar in size to 
MS2, is a single strand RNA virus, and is non-enveloped (Hogle, 2002).  Verreault 
observed that “structure of a virus alone cannot be used to predict the survival of the virus 
under different environmental conditions” however (Verreault, Moineau, & Duchaine, 
2008).  For example, the stability of the St. Louis Encephalitis virus is not affected by 
relative humidity (Verreault, Moineau, & Duchaine, 2008).  Structurally similar 
surrogates may not show this tolerance over broad humidity ranges.  Therefore, even a 
well chosen surrogate may not exhibit similar characteristics to the target virus despite 
the similarity in size and structure.  For this reason, evaluations of Air Force sampling 
equipment should use multiple viral surrogates to ensure that bias is not introduced due to 
characteristics specific only to a single agent.     
 
Alternatives to the Use of Viral Surrogates 
The broad range of studies using surrogate viruses in place of a pathogen show that the 
use of surrogate viruses has value primarily because there is little alternative available at 
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a reasonable cost and acceptable level of safety.  The only alternative to using surrogate 
virus is to use an inert particle of similar size, such as polystyrene latex beads.  
Polystyrene latex beads were used by Hogan to evaluate the collection of submicrometer 
particles by bioaerosol sampling equipment (Hogan, Kettleson, Lee, Bamaswami, 
Angenent, & Biswas, 2005).  While these inert particles can provide data to evaluate a 
sampling method for a particle size range of interest, it is not possible to determine the 
effect of the sampling method on virus viability.  Air Force evaluations on air sampling 
equipment should evaluate particle size collection efficiencies using inert particles 
separately from studies on viral aerosols.     
 
Low Volume Sampling Methods 
Several low-volume sampling methodologies have been evaluated and described in 
current literature for the collection of airborne virus.  While low volume air samplers 
have many limitations, their development and evaluation is necessary to determine the 
relative effectiveness of other sampling methods, such as high volume samplers.  Three 
evaluated technologies include the AGI-30, the Biosampler, and the Fritted Bubbler. 
 
Collection Mechanisms for Low Volume Air Sampling  
The AGI-30 and Biosampler utilize a right angled collection tube to limit particle 
collection sizes to those below a respirable size of approximately 10 micrometers.  Liquid 
collection devices, such as these, have an advantage over other collection methods since 
most biological analytical methods require liquid media (Hogan, Kettleson, Lee, 
Bamaswami, Angenent, & Biswas, 2005).  The use of a liquid collection device prevents 
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the need to transfer a sample into a liquid media after collection thus preserving more of 
the sample for analysis.  The disadvantage of liquid aerosol collection is loss of sampling 
media due to evaporation.  This fluid loss can result in the reaerosolization of virus and 
potentially reduce the collection efficiency (Hogan, Kettleson, Lee, Bamaswami, 
Angenent, & Biswas, 2005).  The AGI-30 uses a 1 mm diameter nozzle that is placed 30 
mm above the bottom of the collection vessel and 10 mm above the surface of the 
collection media.  This placement produces a sharp turn in the streamline of the airflow at 
the outlet, forcing particles with higher inertia to penetrate the liquid and become trapped.  
The Biosampler is a “swirling aerosol collector” that uses three 0.63 mm nozzles to 
create a swirling action in the media which also causes particles to penetrate the fluid and 
become trapped (Hogan, Kettleson, Lee, Bamaswami, Angenent, & Biswas, 2005).  
Fritted bubblers are typically used in gas capture as opposed to bioaerosol particle 
collection.  Bubblers use a glass frit at the end of the collection tube where the air stream 
contacts the media.  This porous frit causes bubble formation that allows the interception 
of particles through an impaction mechanism with the bubble.  Very small particles will 
also diffuse to the air-liquid interface of the bubbles thus allowing capture.   
 
Evaluation of Low Volume Air Sampling Methodologies 
A study conducted by Hogan et al. attempted to compare the collection efficiencies of 
different bioaerosol collection devices, including the AGI-30, Biosampler, and Fritted 
Bubbler.  This study used MS2 and T3 bacteriophage solutions and atomized the viral 
solution to create ultrafine particulate aerosols.  This study is relatively novel in that it 
compared the collection efficiencies for submicrometer particles and ultrafine particles 
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with diameters of less than 100 nanometers (Hogan, Kettleson, Lee, Bamaswami, 
Angenent, & Biswas, 2005).  Prior studies had focused on aerosol particle sizes of 
approximately one micrometer in diameter or larger.  There is a concern that ultrafine 
particles could transfer by diffusion through the alveolar membrane thus providing a 
route of entry into the blood stream.  The Hogan et al. study found that all three evaluated 
samplers were inadequate in the sampling of ultrafine particles with collection 
efficiencies below 10%.  The Fritted Bubbler was the least efficient in the collection of 
ultrafine particles and the AGI-30 was found to be the most efficient although still below 
10%.  All three samplers demonstrated sharp increases in collection efficiency as particle 
diameter increases above 100 nm.  Extremely small particles with diameters less than 30 
nm showed an increase in collection efficiency as particle diameter decreases due to 
tendency of these particles to diffuse into the media (Hogan, Kettleson, Lee, Bamaswami, 
Angenent, & Biswas, 2005).  However, most viruses are larger than this diffusive size 
range.  Hogan et al. also evaluated collection efficiencies of the samplers at different flow 
rates.  The manufacturer specified flow rate for all three samplers is 12.5 liters per minute 
(lpm).  The study found that found that for flow rates less than 2.5 lpm, very little media 
depression occurs in the AGI-30 and the fluid remains motionless in the Biosampler, thus 
preventing the desired swirling motion.  Turbulent liquid motion is observed in the AGI-
30 at flow rates higher than 2.5 lpm and in the Biosampler at flow rates higher than 8.7 
lpm.  The collection efficiencies were evaluated at flow rates of 6.25 lpm and 12.5 lpm.  
The AGI-30 and Biosampler were more efficient at 12.5 lpm, while the Fritted Bubbler 
had higher efficiencies at 6.25 lpm.  The three samplers were also evaluated for particle 
collection efficiency and virus viability as a function of sampling time.  The AGI-30 and 
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Biosampler demonstrated relatively steady particle collection efficiency over time, while 
the Fritted Bubbler shows an increase over time due to the deposition of particles in the 
frit.  The Fritted Bubbler also has a high rate of media loss resulting in a higher virus 
concentration simply due to the evaporation of the fluid.  MS2 loses viability in the AGI-
30 for sampling periods greater than 30 minutes, indicating that viral collection with the 
AGI-30 should be limited to less than 30 minutes.  There was very little correlation in the 
viability of MS2, as compared to T3 indicating that generalizations cannot be made 
across different viruses.  Similar to previously conducted studies, such as those by Tseng 
and Li, this demonstrates that viral surrogates may not accurately simulate pathogenic 
viruses (Hogan, Kettleson, Lee, Bamaswami, Angenent, & Biswas, 2005).  Hogan’s 
study evaluates many of the potential variations associated with using liquid collection 
devices for viral aerosol.  Comparing Hogan’s results to those obtained in studies of 
aerosol particles greater than 1 micrometer could prove valuable in assessing the entire 
collection of a viral aerosol across the entire range of particle sizes.  The paper did not 
account for potential variation from different collection media since a single media, 
phosphate buffered saline (PBS), was used as the liquid collection media for all sample 
runs.  The study did not account for collection efficiency variation due to changes in 
temperature and humidity.  The Hogan study is also limited in that it does not explore the 
processes responsible for the low collection efficiencies observed.  A study 
commissioned by the Air Force Research Laboratory and conducted by Riemenschneider 
et al. sought to determine the impact of reaerosolization in the sampling of viral aerosols 
(Riemenschneider, et al., 2009).  This study examined the AGI-30 and the Biosampler. 
Similar to the Hogan study, flow rates and sampling time were varied, but used to assess 
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the impact of reaerosolization on sampling efficiency.  Sample evaluations were also 
conducted with an inert aerosol tracer, poly styrene latex (PSL), and live MS2 virus.  
Similar to Hogan et al., the Riemenschneider study found that collection efficiency was 
lower when flow rates differ significantly from the recommended 12.5 lpm, with higher 
flow rates greatly increasing the reaerosolization of both virus and PSL.  The 
Riemenschneider study also used a single collection fluid, deionized water, as a 
collection media. Riemenschneider was more thorough than the other authors in 
explaining this selection over other collection media, such as phosphate buffered saline 
(PBS), which is commonly used in liquid collection systems.  The use of saline solutions 
can create salt aerosols that can make it difficult to distinguish the reaerosolization of 
virus (Riemenschneider, et al., 2009).  The Biosampler was also found to have a 
significantly lower reaerosolization rate as compared to the AGI-30; although sampling 
durations greater than 30 minutes were found to increase the reaerosolization in the 
Biosampler.  Further studies should be conducted to determine the impact that longer 
sampling durations have on virus viability, in addition to the affects of the collection fluid 
selected.  This observation also indicates that initial studies on air sampling equipment 
should select a lower sampling time to minimize the effects of sampling durations on 
liquid collection systems, and thus remove this potentially significant variable.  Of the 
three low volume samplers evaluated in these reviewed studies, only the AGI-30 and 
Biosampler are widely described in published literature relevant to the sampling of viral 
aerosols.  Therefore, evaluation of high volume air sampling equipment should include 
either an AGI-30, Biosampler, or both as a standard reference to compare collection of 
virus particles. 
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Collection Media 
 The collection media used in the air sampling of viral aerosols can also impact the 
collection of virus.  A study by Hermann et al. compared various additives to PBS.  This 
comparison was made to optimize a sample collection process for porcine reproductive 
and respiratory syndrome virus (PRRSV).  PBS is a media commonly used for impinger 
collection methods.  Hermann et al. compared the addition of 1% activated carbon, 0.5% 
bovine serum albumin, and 20% ethylene glycol to PBS.  Combinations of these 
additives were evaluated as well.  None of the additives tested had a significant impact of 
the collection efficiency of virus, and all solutions and additives were within 10% of the 
PBS results without additives.  Ethylene Glycol and PBS was shown to be slightly more 
effective than the baseline PBS for the collection of PRRSV, and could warrant further 
study.  Ethylene Glycol, commonly used in antifreeze, has a lower freezing point than 
PBS and water and could be used where operations in cold environments were required 
(Hermann, Hoff, Yoon, Burkhardt, Evans, & Zimmerman, 2006).  The Hermann et al. 
study was limited due to the use of PCR for quantification of sample results.  Therefore, 
maintenance of viable virus during sampling was not considered by Hermann.   
 
Remel M5 Solution as a Collection Media 
Most of the reviewed studies on the liquid collection of viruses used either PBS solution 
or sterile water.  One limitation of these collection media is that they are unable to 
preserve the virus for extended time periods (Escamilla, 2009).  This could be a 
particularly important limitation in many military operating environments, where sample 
transport over a long distance could be required for laboratory analysis.  Fortunately, 
 
40 
transport media is available for the extended preservation of viruses including Remel M5.  
Remel M5 media has been shown to be effective at preserving virus for up to 48 hours 
after specimen collection (Remel, 2005).  Remel M5 has not been described in published 
literature for the collection of air samples, and no literature is available to support its use 
for this purpose.  Liquid impingers also produce a foaming effect, especially when the 
collection media contains proteins or carbohydrates.  Remel M5 media contains both of 
these constituents in its formulation, which could be a key limitation in selecting Remel 
M5 as a collection media in impingers due to re-aerosolization of the collected virus in 
the impinger.  Antifoam solutions can be used to reduce this foaming effect.  Six 
antifoamants were evaluated for their impact on viral infectivity by Hermann and none 
were shown to have a significant impact on viral infectivity.  Four of the six antifoamants 
did significantly affect the host cells however (Hermann, Hoff, Yoon, Burkhardt, Evans, 
& Zimmerman, 2006).  If further foaming reduction is required, the air flow rate into the 
impinger can be reduced, although doing so could have a significant impact on sampler 
performance, as discussed earlier in both the Hogan and Riemenschneider studies.  Dycor 
Technologies has developed a flow reducer for the XMX/2L-MIL for this purpose, but it 
has not been evaluated for performance in the sampling of a viral aerosol.  Therefore, it is 
evident from the existing data that a virus preserving collection media, such as Remel 
M5, should be evaluated for use in Air Force sampling equipment to improve the 
sampling and analysis of viral aerosols, despite the inherent limitations due to the 
foaming.  The selection of an effective virus preserving sample media would enhance the 
use of Air Force air sampling equipment in deployed environments.      
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High Volume Sampling  
The urgency required for field sampling in response to a suspected biological agent 
release typically does not allow for the use of low volume sampling devices.  
Additionally, due to the dilutive effects of an open atmosphere, sampling in response to 
an outdoor release of a biological agent requires a large sample volume to better ensure 
the ability to assess the potential human environmental exposure.  To meet these urgent 
detection and analysis requirements, high volume sampling methodologies should be 
used.  High volume sampling enables the collection of dilute aerosols, such as those in an 
outdoor environment (Cox & Wathes, 1995).  This capability comes with limitations,  
however.  Cox and Wathes describe these limitations in their Bioaerosols Handbook 
(Cox & Wathes, 1995).  Aerosol integrity can be compromised by high volume air 
sampling.  Use of high volume air samplers in an indoor environment “may strip the 
biological particles faster than the regeneration rate.”  This stripping effect of this can 
result in the “misrepresentation of the bioaerosol concentration” (Cox & Wathes, 1995).  
This deficiency could be very significant for sampling in a laboratory exposure chamber.  
The rapid stripping of the aerosol may create particular difficulties in the evaluation of 
high volume samplers using an exposure chamber with limited volume and aerosol 
regeneration.  Therefore it is necessary to properly monitor the aerosol concentration 
during the evaluation of high volume sampling systems using a chamber. 
 
Laboratory Studies of XMX/2L-MIL Air Sampling for Viral Aerosols 
Dycor Technologies conducted an unpublished study to determine if the XMX/2L-MIL  
effectively recovers aerosolized virus.  These studies were conducted using a standard 
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configuration XMX/2L-MIL with PBS collection media in a 12 cubic meter exposure 
chamber.  This study consisted of 5 trials using MS2 bacteriophage with an airborne viral 
target load of 25 agent containing particles per liter of air.  Results are shown in Table 2.  
The MS2 collected in this study by the XMX/2L-MIL are approximately equivalent to an 
aerosol concentration measurement of 891 PFU/Liter of Air. 
 
 
Trial ACPLA Sample Concentration (PFU/ml) 
1 23.6 485000 
2 23.0 445000 
3 28.1 490000 
4 25.3 472500 
5 23.2 447500 
Average 24.6 468000 
 
Table 2: MS2 Collection with XMX/2L-MIL 
(Dycor Technologies, 2009) 
 
 
These results demonstrate the feasibility of using the XMX/2L-MIL to recover infectious 
virus.  Dycor did not evaluate multiple viral loads or decontamination of the XMX/2L-
MIL.  Additionally, these results were collected with a single XMX/2L-MIL per trial run.  
Therefore, intra-instrument variability could not be assessed using the data obtained in 
this study.  Published studies concerning the collection of viruses in a laboratory setting 
are not available for the DFU-1000; therefore, the overall effectiveness of DFU-1000 
cannot be assessed from existing literature.  This data on collection of MS2 using PBS as 
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the collection media, could be used as a baseline to which other sample media, such as 
Remel M5, could be compared. 
 
Field Studies  using the XMX/2L-MIL for Viral Air Sampling 
High volume air sampling for viral aerosols in the field has been performed with the 
XMX/2L-MIL, or similar systems, in at least two separate studies.  The first study 
conducted in 1988 by Brenner et al. used a prototype XM2 with functions similar to the 
XMX/2L-MIL (Brenner, Scarpino, & Clark, 1988).  The XM2 used a combination of 
virtual impaction followed by liquid impingment, and was used for air sampling during 
the land application of wastewater.  Brenner et al. was able to recover active 
bacteriophage from the XM2 sampling media.  Bacteriophage concentrations measured 
by the XM2 ranged from 0 to 9 plaque forming units (PFU) per cubic meter of air 
(Brenner, Scarpino, & Clark, 1988).  The XMX/2L-MIL was used during an H7N3 avian 
flu investigation conducted by Schofield et al. in 2005.  Schofield collected samples 
inside a barn where infected birds were present and in a nearby command post.  
Downwind samples and random samples in the local area were collected as well.  PCR 
detection and semi-quantitative PCR were used for analysis.  The two samples collected 
inside the barn yielded positive results and relatively high estimates of viral load using 
the semi-quantitative analysis (Schofield, Ho, Kournikakis, & Booth, 2005).  
Additionally, live virus was extracted from these samples.  The four samples collected 
near the command post were found to be positive for H7N3 by PCR detection; however, 
the less sensitive semi-quantitative PCR was not able to detect H7N3.  The authors 
concluded that these results were false positives caused by residual material associated 
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with previous sample collection performed inside the barn.  One sample taken downwind 
in the local area was found to be positive for PCR detection, but was negative using semi-
quantitative PCR analysis.  However, the possibility of cross contamination from other 
samples was ruled out.  This sample was thus considered a true positive (Schofield, Ho, 
Kournikakis, & Booth, 2005).  The studies by Dycor and Brenner et al demonstrate that 
viable virus is capable of surviving XMX/2L-MIL collection under field sampling 
conditions.  The residual contamination present between samples in the Schofield study 
demonstrates the need for an effective strategy to decontaminate the XMX/2L-MIL after 
exposure following any sample event.   
 
Field Studies using the DFU-1000 for Viral Air Sampling 
The DFU-1000 was used in one published field study for viral air sampling.  This study 
conducted by Russell in 2006, involved environmental sampling for adenovirus subtype 4 
in a Marine Corps training area in San Diego, California.  Air samples were collected in 
squad bays using both the DFU-1000 and an electrostatic precipitator.  A total of 20 
samples were collected with the electrostatic precipitator and 19 with the DFU-1000.  
Forty-two percent of the samples collected with the DFU-1000 were positive for 
adenovirus and 50 percent were positive for the electrostatic precipitator (Russell, et al., 
2006).  Samples were analyzed using PCR only; although some samples were randomly 
selected for viral culture analysis.  Because the samples were analyzed using PCR, the 
ability of the DFU-1000 to recover viable virus from field samples cannot be determined; 
however, this study does demonstrate the potential for detection of virus under field 
conditions using the DFU-1000.  The Russell study does not provide results on the 
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recovery of viable virus; therefore, the effectiveness of the DFU-1000 in a situation 
where viable quantification of airborne is needed, or where confirmatory sample analysis 
by culture is desired.  These studies indicate that the DFU-1000 may be suitable for the 
field collection of viral agents of interest and should be evaluated with other equipment 
currently inventoried by the Air Force.  The existing data from both field and laboratory 
studies indicate that Air Force high volume air sampling equipment can be used to 
recover both viable and non-viable air samples and should be comparatively evaluated to 
optimize their use in the field.           
 
Virtual Impaction 
Some air sampling systems with applications to bioaerosols, such as the XMX/2L-MIL, 
use a virtual impaction process to split an incoming air flow in two fractions of minor and 
major flows, with the “minor flow containing larger particles above a certain cutoff size” 
(Cox & Wathes, 1995).  This splitting allows the production of a concentrated aliquot of 
flow rich in particles relative to the ambient concentration.    Often, several of these 
virtual impactors are used in a multistage series to further increase the concentration of 
the particle rich airflow.  Such a multistage virtual impaction system was described by 
Romay in which a three stage virtual impaction system was evaluated.  This system 
reduced an initial flow of 300 lpm to 1 lpm, while maintaining 50 to 90 percent of the 
total particle load in the desired 2.3 to 8.4 micron size range (Romay, Roberts, Marple, 
Liu, & Olson, 2002).  One potential disadvantage of using virtual impaction in the 
collection of viral containing particles is the high efficiency at which particle sizes of 2 
microns and less are eliminated from the minor flow stream.  The multistage virtual 
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impaction bioaerosol sampler used by Romay had a 62 percent capture efficiency for the 
2.31 micron sized particles, but only a 28 percent efficiency for the 1.95 micron sized 
particles (Romay, Roberts, Marple, Liu, & Olson, 2002).  These results could indicate 
very low particle collection efficiencies for sizes less than the 1 micrometer cutoff used in 
the design of the XMX/2L-MIL.  This may cause the XMX/2L-MIL to significantly 
under represent a viral aerosol consisting largely of submicrometer particles.  Further 
laboratory analysis could confirm if these limitations are a significant contributor to the 
ability of the XMX/2L-MIL to fully characterize a virus containing aerosol.     
 
Filter Sample Collection and Extraction 
Collection by filtration offers many benefits in the sampling of viral aerosols, including 
greater collection efficiencies of submicron viral particles (Verreault, Moineau, & 
Duchaine, 2008).  An evaluation of filter performance in the collection of nano sized 
particles and viruses was conducted by Burton et al. and found relatively high collection 
efficiencies.  Polytetrafluoroethylene (PTFE) filters with 0.3, 0.5, 1, and 3 micron pore 
sizes, polycarbonate (PC) filters with 1 and 3 micron pore sizes, and gelatin filters were 
simultaneously evaluated.  Physical collection efficiency was evaluated using MS2 virons 
and inert sodium chloride particles.  For MS2 collection, the PTFE filters were all similar 
in performance, with the 0.3 and 1 micron pore size filters recovering approximately 
100% of the MS2 viral particles, and the 3 micron pore size filters recovering 
approximately 95% (Burton, Grinshpun, & Reponen, 2007).  The PC filters demonstrated 
significantly lower MS2 collection efficiencies compared to the PTFE.  The 1 micron PC 
filter had a physical collection efficiency of approximately 70% and an approximately 
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30% efficiency for the 3 micron PC filters.  For inert sodium chloride particle collection, 
the 0.3 micron and 3 micron sized PTFE filters demonstrated a near 100% collection 
efficiency for all particle sizes in the test range of 10 to 500 nanometers.  The collection 
efficiency of the 1 micron PC filters ranged from 50% to 100% over the test range and 
30% to 60% for the 3 micron filters (Burton, Grinshpun, & Reponen, 2007).  These 
collection efficiencies compare very favorably to the collection efficiencies measured by 
Hogan for the AGI-30, Biosampler and the Fritted Bubbler.  The physical collection for 
these liquid samplers was 10% or less over the 25 to 100 nanometer particle size range 
(Hogan, Kettleson, Lee, Bamaswami, Angenent, & Biswas, 2005).  The Burton study has 
some important limitations in its application however.  First, the flow rate for the filter 
samplers was 4.0 lpm, therefore the data from this low volume collection may not be 
applicable to the high flow rates used by the DFU-1000.  Second, the data for the MS2 
recovery was obtained using only real time quantitative PCR, plaque assays were not 
taken to determine viral infectivity after collection.  These studies show that filter 
collection of viral aerosols with the DFU-1000 may be effective.  A further study could 
determine if the conditions produced by high volume collection negate the advantages of 
filter collection shown in these studies, however.    
 
Limitations to the Use of Filters in Air Sampling 
The advantages filter collection offers in fine and ultrafine particle size collection offset 
by some critical limitations.  The primary limitation to the use of filters for viral air 
sampling is the extraction of the sample from the filter.  This extraction is typically 
required for analysis, and often a large amount of sample cannot be recovered from the 
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filter.  In studies conducted by the Occupational Safety and Health Administration 
(OSHA), a 68 percent sample removal efficiency was obtained during filter extraction 
from the polyester felt DFU-1000 filters (Lawrence, 2003).  A study conducted by the 
United States Environmental Protection Agency (EPA) evaluated the extraction 
characteristics of MS2 bacteriophage from a filter surface.  Filters were seeded with 
“medium” concentrations of MS2 (6.7 x 104 PFU/Filter) and high concentrations of MS2 
(5.2 x 105 PFU/Filter).  Extraction was accomplished by placing the seeded filter in a 
tube containing PBS solution and then shaking the tube for 30 seconds, followed by 30 
seconds of vortexing (EPA, 2009).  For the medium seeded filters, extractions of between 
21 and 52 percent of culturable MS2 were observed.  The high seeded filters achieved 
extraction efficiencies of around 100 percent.  Although the results from these seeded  
filters may not be an exact representation of MS2 in a filter after air sampling, these 
results indicate that as the MS2 concentration of the filter of the DFU-1000 increases, 
extraction effectiveness will also likely increase.  The lower extraction efficiencies for 
medium seeded filters likely limits the effectiveness of using the DFU-1000 when a low 
concentration of viral agent is present.     
   
Improvements to Filter Extraction 
Methods to improve the retrieval of bioaerosol samples from a filter have been 
researched as well.  Burton et al. compared filter extraction methods, vortex with 
ultrasonic agitation and vortex with shaker agitation, for bacterial surrogates for B. 
anthracis.  Both methods involved vortexing the filter and sample for 2 minutes, 
followed by agitation for 15 minutes.  This study found that both methods were capable 
 
49 
of extracting culturable sample from the filter, but that vortex with shaker agitation 
produced “significantly higher physical extraction efficiency for both mixed cellulose 
ester (MCE) and polytetrafluoroethylene (PTFE) filters” (Burton, Grinshpun, & Hornung, 
2005).  Residual sample remaining on the DFU-1000 filter is expected to significantly 
reduce the collection effectiveness of this method; however, the degree to which this 
impacts the ability to accurately assess the presence and magnitude of a viral agent is 
unknown.       
 
Analytical Methods as Used in Literature 
Technological developments have greatly advanced laboratory and field analytical 
methods since the early studies on viral agents conducted in the 1960’s.  These early 
studies required active viral cultures using a variety of culture methodologies, including 
inoculation into chicken embryos and plate cultures.  While active viral cultures can still 
provide confirmation of a positive result, and must still be used to study viral infectivity, 
they are of little use in a response environment.  In addition to the time requirements, 
viral isolation and culture is very resource intensive, as well as requiring large amounts of 
consumable supplies and laboratory support equipment along with sterile working 
conditions (Fatah, Arcilesi, Chekol, Lattin, Shaffer, & Davies, 2005).    Fortunately, other 
analysis methods are available today that are able to provide fast detection and 
presumptive identification for viral agents to base level first responders.  These methods 
include immunochemical based techniques and polymerase chain reaction (PCR). 
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Viable Culture Methods 
In order to detect or quantify viable virus, a laboratory based culture method must be 
used.  The primary method of quantifying viruses is through the use of a plaque assay.  A 
plaque assay involves mixing a certain dilution of a virus preparation with susceptible 
host cells, and spreading this mixture on a nutrient plate.  After incubation, the host cells, 
or bacteria in the case of plaque assay for bacteriophages, form a film on the plate with 
clearings.  These clearings in the film are plaques and are representative of the virus in 
the sample (Adams, 1959).  The number of plaques counted is directly propotional to the 
number of viruses present in the sample.  For bacteriophages, each plaque can “be 
understood as a phage colony containing the decendants of a single phage particle” 
(Adams, 1959).  Every phage present in the sample will not produce a plaque; therefore, 
plaque counts should be used as a relative method of quantification as opposed to an 
absolute quantification (Adams, 1959).  A relative quantification method is all that is 
required for the comparison of air sampling equipment since the limitations to 
quantification described by Adams would be present in each plaque assay conducted as 
part of the comparative analysis. 
 
Immunochemical Analysis   
Immunochemical based techniques include hand held assays (HHA) and enzyme linked 
immunosorbent assays (ELISA).  These analysis methods provide quick turnaround times 
to response personnel.  HHAs are regularly employed by Bioenvironmental Engineering 
and Civil Engineering Emergency Management for on scene detection.  These simple 
devices can be used to detect a variety of biological agents including variola (Peruski & 
 
51 
Peruski, 2003).  Immunochemical processes have significantly high detection limits, 
however.  For detection of bacterial agents, such as B. anthracis, detection limits of 
approximately 10,000 colony forming units per milliliter of sample (CFU/ml) were 
required (Peruski & Peruski, 2003).  ELISA methods were also developed and evaluated 
for the rapid detection of Ebola virus and for “Ebola like particles” by the United States 
Army Medical Research Institute of Infectious Diseases (USAMRIID) in a study 
conducted by Kallstrom et al.  The Kallstrom study found that ELISA could be used in 
the detection of Ebola virus, with detection limits of approximately 500 to 1000 plaque 
forming units in an analyzed sample.  Similar to PCR, ELISA does not require infectious 
virus for detection.  For example the Kallstrom study used an irradiated Ebola virus 
sample in their analysis (Kallstrom, et al., 2005).   
 
PCR Analysis 
Although immunochemical based techniques provide a rapid detection method that is 
reasonably effective, the limits of detection are still a concern for these methods.  The Air 
Force utilizes PCR as its presumptive detection methodology in response to a biological 
agent release.  PCR provides a much lower limit of detection than immunochemical 
methods.  For detection of B. anthracis, PCR techniques provide a limit of detection in 
the range of 1 to 100 CFU/ml of sample, which is much lower than the immunochemical 
limit of 10,000 CFU/ml (Peruski & Peruski, 2003).  PCR allows for a small amount of 
DNA in a sample to be multiplied through a series of cycles that effectively doubles the 
amount of target sequence DNA per cycle.  RNA viruses such as MS2 do not contain 
DNA, therefore an additional step known as reverse transcriptase, is required.  This 
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process uses the enzyme reverse transcriptase to synthesize complementary DNA from 
RNA.  This synthesis process then allows the complementary DNA to be used in PCR for 
detection.  Real-time reverse transcriptase fluorogenic PCR was developed by O’Connell 
et al. for the analysis of MS2 bacteriophage.  Fluorogenic PCR uses a fluorogenic probe 
that increases in florescence in the presence of the target DNA sequence (O'Connell, et 
al., 2006).  This florescence provides a measurable metric and a threshold of the change 
in florescence is set to denote the presence of the DNA in a sample.  O’Connell 
developed and tested five separate primer and probe sequences for MS2 (O'Connell, et 
al., 2006).  For biological agent detection using the JBAIDS, sample reagents containing 
these primer and probe sequences are prepared specifically for each agent of interest.  
O’Connell evaluated each sample for up to 45 cycles, and results were provided as the 
number of cycles required for the target sequence to reach a threshold level of detection.  
There was some variation in the number of cycles required for detection based on the 
probe and primer sequences used.  This variation led to a change in the limit of detection. 
For example, one of the five probe/primer sequences was capable of detecting 0.4 
picograms (pg) of MS2 in a sample.  Two of the five probe/primer sequences were 
capable of detecting 4 pg of MS2 in a sample, while all five sequences were capable of 
detecting 400 pg of MS2 in the sample (O'Connell, et al., 2006).  This study demonstrates 
the importance of properly selecting the probe/primer sequences for viral sample analysis 
using PCR and the low levels of detection available in PCR analysis.  The O’Connell 
study also highlights some of the many difficulties in using PCR as a quantitative 
analysis method, since just the selection of probe and primer sequences greatly affected 
the sensitivity of the analysis.      
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Limitations of PCR Analysis 
A critical issue associated with any laboratory analysis method for biological agent 
detection is the potential for false positives.  This limitation was considered in the 
selection of the JBAIDS.  The acquisition testing specifications for the JBAIDS required 
a false positive rate for variola of no more than 10%, or specificity of 90% (Wilson, 
2006).  Actual contractor validation testing of the JBAIDS obtained a specificity of 99%.  
This specificity testing evaluated the ability of the JBAIDS to distinguish variola from 
vaccinia, which is a closely related virus.  Sensitivity requirements were also included in 
the JBAIDS evaluation criteria.  One pass or fail criteria for sensitivity required that the 
JBAIDS be capable of identifying vaccinia virus 85% of the time.  Actual operational 
testing results for vaccinia obtained a sensitivity of 90.4%.   Similar testing was 
conducted for Ebola and Venezuelan Equine Encephalitis virus, and sensitivity of 100% 
was obtained (Wilson, 2006).  Some viral analysis using the JBAIDS did result in lower 
sensitivities.  For example, the operational testing sensitivity for Marburg was 78.5% 
(Wilson, 2006), or a false negative rate of more than 1 in 5.  While limited in its 
application, the high levels of sensitivity and specificity allow the JBAIDS to provide a 
standalone presumptive detection methodology during response to a biological agent 
release.  Due to the widespread use of PCR analysis and its proven capabilities, all 
evaluations on Air Force biological air sampling equipment should incorporate PCR 
analysis as an assessment criterion.      
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Decontamination 
The limited availability of air sampling equipment during a response to biological agent 
release requires that effective decontamination methods and materials be available to 
allow for multiple samples to be taken with a single piece of equipment.  Ideally, one 
decontamination methodology would be applicable to all biological air sampling 
equipment.   The manufacturer of the XMX/2L-MIL, recommends that removable 
canister components be submerged in a 10% bleach (sodium hypochlorite) and water 
solution for 5 to 10 minutes then rinsed with tap water followed by rinsing with distilled 
water (Dycor Technologies, 2001).  The manufacturer does not provide additional 
guidance on decontamination procedures for specific microbial agents, requiring the user 
to develop these procedures.  As shown by Schofield et al., eliminating cross 
contamination between samples collected using the XMX/2L-MIL is very important 
(Schofield, Ho, Kournikakis, & Booth, 2005).   
 
Decontaminating Agents 
A variety of chemical and physical processes have been used for decontamination of air 
sampling equipment.  The adenovirus and meningitis study conducted by Artenstein used 
a single high volume sampler, and thus required decontamination between trial runs.  The 
decontamination method used was a dual wash and rinse process involving a wash in a 
solution of 70% alcohol and a rinse with distilled water (Artenstein, Miller, Lamson, & 
Brandt, 1968).  Decontamination effectiveness was not separately evaluated in the 
Arttenstein et al. study.  USAFSAM has evaluated decontamination procedures and 
methods for the XMX/2L-MIL.  These prior studies on the XMX/2L-MIL were limited to 
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bacterial agents, and focused only on decontamination for the XMX/2L-MIL.  These 
studies used Bacillus atrophaeus, a spore forming organism commonly used as a 
surrogate for Bacillus anthracis, and Bacillus subtilis as a surrogate for Yersinia pestis 
(LaRoche, 2009).    The first study compared two methods of decontamination using a 
10% bleach solution.  The first method evaluated involved wiping the canisters of the 
XMX/2L-MIL with the bleach solution, while the second method submerged the 
canisters in the bleach solution.  The study found that there was no statistically significant 
difference between the two methods, and confirmed prior studies, which found that 
hypochlorite is an effective decontaminating agent.  Operator error can be a significant 
factor for the wipe decontamination method however; therefore, the study recommended 
that field decontamination use the submersion method (LaRoche, 2009).  A second study 
conducted by USAFSAM evaluated the effectiveness of three solutions for 
decontamination; 5% bleach, 10% bleach, and 3% hydrogen peroxide (Lohaus, et al., 
2009).  All three solutions were found to be effective for the decontamination of bacterial 
agents.  Decontamination by hypochorite bleach was selected by USAFSAM for further 
evaluations due to its widespread commercial availability and anti-microbial 
effectiveness.   
 
Sensitivity of Viruses to Decontamination 
While viral agents are less resistant to decontamination than bacterial spores and 
mycobacteria, small non-enveloped viruses are still more resistant than both gram-
negative and gram-positive bacteria.  Large non-enveloped viruses and lipid enveloped 
viruses are some of the least resistant organisms to decontamination (LaRoche, 2009).  
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The relative sensitivities of different classes of microbes to decontamination is shown in 
Figure 5.     
 
 
 
Figure 5: Resistance of Microorganisms to Decontamination 
(Adapted from LaRoche, 2009) 
 
       
Surface Decontamination of Air Sampling Equipment 
The non-expendable surfaces subject to contamination on the XMX/2L-MIL are 
unpainted and painted metal, while the surfaces on the DFU-1000 are primarily plastic, 
foam plastic, and coated plastic.  This difference in surfaces introduces two potential 
limitations to applying previous studies; the ability of the decontaminant to penetrate the 
surface and the sensitivity of the material surface to corrosion and degradation from the 
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decontaminant.  Sodium hypochlorite is very corrosive and can impact the operation of 
sensitive equipment; however, the LaRoche study noted that corrosion was unlikely to be 
a significant risk to the performance of the XMX/2L-MIL (LaRoche, 2009).  LaRoche  
measured the presence of contamination on the surfaces of the air sampling equipment by 
using cotton swabs soaked in PBS solution (LaRoche, 2009).  While swabbing can be an 
effective technique in identifying contamination, it has several limitations.  Rose et al. 
evaluated the recovery of Bacillus anthracis (BA) from a steel surface using swabs.  Four 
different swab materials were used, including cotton, macrofoam, polyester, and rayon.  
Extraction effectiveness and the effectiveness of pre-moistening the swab prior to sample 
collection were also evaluated.  The authors found that macrofoam and cotton produced 
the greatest recovery of BA and that pre-moistening the swab increased sample 
collection.  Vortexing was more effective in extracting sample from the swab than 
sonication.  However, recovery was still relatively low, with the cotton swabbing only 
recovering 27.7 percent of the BA on the surface (Rose, Jensen, Peterson, Banerjee, & 
Arduino, 2004).  A follow-on study conducted using macrofoam swabs found that the 
percentage of sample recovered on the swab decreased significantly when lower 
concentrations of BA were present on the surface (Hodges, Rose, Peterson, Noble-Wang, 
& Arduino, 2006).  These lower sensitivities at low concentrations could be a significant 
limitation to using surface swabs for post-decontamination evaluation when there are 
very low concentrations of surface contamination.  Furthermore, it is of interest to note 
that the studies conducted by Rose and Hodges used BA, a spore-forming bacteria.  As 
shown in Figure 5, spore forming bacteria are more resistant than viruses.  Therefore, 
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using swabs in the evaluation of viral contamination may be even less effective than 
using swabs to measure bacterial contamination. 
 
Limitations of Previous Decontamination Studies  
One key limitation to the decontamination studies conducted by USAFSAM was that  
decontamination effectiveness was not evaluated for equipment reuse when using PCR 
analysis methods (LaRoche, 2009).  Since PCR does not require a viable organism for 
detection, DNA and RNA residuals from previous sampling could result in a positive 
result during PCR analysis, despite culture analysis indicating the absence of 
contamination.  PCR analysis using the JBAIDS system is the presumptive method of 
identifying biological agents for the Air Force and should be included in all studies 
involving the sampling or decontamination of biological agents.   
 
Problem Statement and Summary 
Previous literature provides a reasonably thorough background to laboratory and field 
studies on the air sampling of viral aerosols.  Previous studies involving the use of high 
volume air sampling for viruses are more limited however.    Since these high volume 
sampling methods are the primary means of response, detection, and risk assessment for 
the Air Force; additional study is necessary.  Experimental evaluations of the XMX/2L-
MIL and the DFU-1000 for the collection of viruses are not available in published 
literature.  Furthermore, no studies comparing performance at different levels of airborne 
viral load have been performed for the XMX/2L-MIL or the DFU-1000.  Evaluating air 
sampling equipment at different levels of airborne viral load could provide information 
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on the effectiveness of viral samplers at lower levels of detection which would be critical 
in a field response.   Side by side comparison of existing high volume methodologies has 
also not been conducted.  Simultaneous comparison of high volume sampling 
methodologies and low volume sampling has also not been completed.  Since low volume 
collection methods such as the AGI-30 and Biosampler are widely evaluated in literature, 
low volume methodologies could be considered a “gold standard” with which to compare 
the XMX/2L-MIL and DFU-1000.  A comparative evaluation of the XMX/2L-MIL and 
the DFU-1000 would provide valuable information on the feasibility of conducting 
laboratory evaluations to guide future purchase decisions of Air Force sampling 
equipment for bioaerosols. 
 
XMX/2L-MIL viral studies have been limited to PBS and water collection media.  
Effectiveness of other solutions such as Remel M5 has not been evaluated for 
performance in viral collection.  This evaluation is necessary to determine if Remel M5 
could be used for field conditions where the use of PBS and water media may not be 
appropriate. 
 
PCR detection has not been evaluated in the previous decontamination studies for the 
XMX/2L-MIL.  Furthermore, no decontamination studies have been completed for the 
DFU-1000.  USAFSAM is performing a complete decontamination evaluation on viral 
agents for the XMX/2L-MIL that includes PCR analysis.  Decontamination effectiveness 
for viral agents should be evaluated as a comparative measure of equipment performance 
for both the XMX/2L-MIL and the DFU-1000.  This comparative evaluation of 
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decontamination should include JBAIDS analysis to ensure that both systems are capable 
of being decontaminated to a level below what the JBAIDS is capable of detecting.  
 
In summary, a comparative evaluation on the effectiveness of Air Force high volume air 
sampling equipment currently present in the inventory is necessary.  This study should be 
based in a controlled laboratory exposure chamber to provide stable aerosol conditions 
and quantify external variables such as aerosol particle size, relative humidity, and 
temperature.  Equipment evaluation should include resources that would be applicable 
and beneficial to a field response, such as the use of virus preserving sample media, and 
detection with a field analysis tool such as the JBAIDS.  This evaluation would not only 
aid in equipment selection for current response use, but would also form a baseline for 
future comparative studies.       
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III.  Methodology 
 
Objective 
This section describes the methodology used for the comparison of the XMX/2L-MIL 
and DFU-1000 high volume air samplers.  Procedures for the comparison of viral aerosol 
sampling effectiveness and field decontamination are developed and described. 
 
Study Design Overview 
The primary means of evaluating sampling equipment for viral aerosols is through the 
use of an aerosol test chamber (ATC), where aerosol concentrations and conditions can 
be measured and monitored.  Due to the high volumetric flow rates of air sampled by 
most high volume samplers, a sufficiently large chamber must be provided.  Laboratory 
analysis methods, surrogate agent selection, and decontamination equipment and 
methodologies must be established as well.  These procedures and selection methods are 
described in this section.  
 
Surrogate Virus and Host Cell Selection  
Male Specific Coliphage 2 (MS2), American Type Culture Collection (ATCC) 15597-
B1, was chosen as the surrogate viral agent for this study.  MS2 offers several advantages 
that are not offered by other agent choices.  Male specific coliphages such as MS2 are 
able to be controlled in the laboratory and cannot propogate in conditions outside the 
laboratory.  The reasons for these qualities of MS2 were described by Riemann as the 
manner that MS2 attaches to and infects the E.-coli bacterium.  “Male specific coliphage 
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strains infect ‘male’ strains of E.-coli via the pilus.”  The pilus only forms in E.-Coli at 
temperatures exceeding 30 degrees Celsius, thus requiring laboratory incubation for MS2 
to propogate (Riemann & Cliver, 2006).  Numerous prior studies have shown that MS2 
can be effectively recovered during air sampling using a variety of methodologies.  MS2 
is an un-enveloped, single strand RNA virus with an approximate size range of 20 to 30 
nanometers.  Un-enveloped viruses have been shown to have greater resistance to 
decontamination and thus represent a suitable worst case for evaluation.  The evaluation 
of viral collection was conducted in conjunction with a decontamination study on the 
XMX/2L-MIL conducted by USAFSAM, and was, therefore, the most suitable agent 
available.  Additionally a virus that is more resistant to environmental conditions, such as 
un-enveloped viruses, is more likely to survive sampling and provide results to which 
equipment comparisons can be made.  Prior studies on high volume air sampling in the 
laboratory setting is limited; therefore using a more resistant virus increases the 
likelihood of obtaining data and being able to compare results between sampling systems.      
 
Chamber Setup and Layout 
Aerosolization studies were conducted in an aerosol test chamber (ATC) provided by 
Dycor Technologies Ltd. in Edmonton, Alberta.  The ATC is 12 cubic meters in volume 
and approximately 3 meters in length, 2 meters wide, and 2 meters high.  A layout of the 
chamber is shown in Figure 6 below.   
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Figure 6: Aerosol Test Chamber Layout 
 
 
Three high volume ports were located approximately 1.9 meters from the point of aerosol 
dispersal.  A schematic showing the full layout of the ATC with component locations and 
measurements of interest is available from USAFSAM.  The chamber was equipped with 
two circulating fans for aerosol mixing.  Particle sizing was measured using a TSI 
Aerodynamic Particle Sizer (APS), model number 3321.  Real-time particle 
concentrations were monitored and maintained using a Grimm Optical Particle Counter 
model 1.108.  The vent hood of the XMX was raised into the ATC to a height of 
approximately 16 centimeters.  The DFU-1000 was attached to a 5 cm diameter copper 
pipe that was raised into the chamber to a height of approximately 16 centimeters, 
consistent with the two XMX/2L-MIL samplers.  Intake height was kept constant among 
instruments to eliminate bias in sampling that might occur by differences in sample 
collection height.  The adaptation of the copper pipe to the DFU-1000 is similar in 
configuration to the adaptation of the DFU-2000 assembly which allows the DFU-1000 
to be used in outdoor environments. A DFU-2000 is shown in Figure 7 and consists of a 
DFU-1000, a plastic housing unit, boom extension, and particle pre-separator.  
 
64 
 
 
    
Figure 7: DFU-2000 (Left) and DFU-1000 (Right) 
 
 
 
Low Volume Air Sampling 
Two low volume air sampling methods were included in each exposure trial; the AGI-30 
and the Biosampler.  These low volume samplers were chosen due to their widespread 
use in prior published studies and proven effectiveness in the collection of particle sizes 
of 1 micron and larger.  These low volume samplers can be used as a comparison 
benchmark for the high volume methods.  The AGI-30 and Biosampler were attached to a 
stand inside the chamber near the DFU-1000 sample port and placed at a height below 
the inlet points of the XMX/2L-MIL and DFU-1000.  This setup is shown in Figure 8.  
Air flow to the AGI-30 was provided by a vacuum line attached to the test chamber. 
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Figure 8: Biosampler and AGI-30 in Aerosol Test Chamber 
 
 
 
The Biosampler was operated using an SKC Vac-U-Go non-compensating vacuum 
pump.  The Vac-U-Go pump was attached to the biosampler through an apparatus that 
included a water trap (Erlenmeyer flask) and field rotameter.  The apparatus connected to 
the Biosampler is shown in Figure 9.  Low volume air sampling equipment was 
calibrated before and after sampling each day using a Bios DryCal DC-2 Air Flow 
Calibrator.  The Bios DryCal DC-2 served as the primary flow calibrator for both the 
AGI-30 and Biosampler.  An SKC field rotameter was used with the biosampler as a 
secondary flow standard.  The AGI-30 was operated at a calibrated flow rate of 12.75 to 
12.80 lpm, and the Biosampler at a calibrated flow rate of 12.5 lpm.  Flow rates for the 
AGI-30 and Biosampler were converted to standard liters per minute (SLPM) using 
temperure and ambient pressure data.  Temperature was monitored during each sample 
collection period.  Ambient pressure data was obtained hourly for Edmonton, AB from 
the Canadian Weather Service.  
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Figure 9: Biosampler Apparatus 
 
 
 
Aerosolization of Viral Solution 
Aerosol Introduction  
MS2 aerosol solution was prepared by diluting a 4.4 x 1010 plaque forming units per 
milliliter (PFU/ml) stock solution with Luria broth.  The MS2 stock solution was diluted 
by a factor of 10 for the high and medium airborne viral loads and by a factor of 100 for 
low airborne viral loads.  Airborne viral loads are presented in terms of agent containing 
particles per liter of air (ACPLA).    The final concentration of aerosol solution is shown 
in Table 3 for each target level of viral load.   
 
Airborne Viral 
Load 
Target ACPLA  Dilution Factor Concentration of 
Aerosol Solution 
High 100 10 4.4 x 109 
Medium 10 10 4.4 x 109 
Low 1 100 4.4 x 108 
 
Table 3: MS2 Aerosol Solution 
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MS2 solution was aerosolized using a Sonotek 8700-48MS ultrasonic atomizing nozzle, 
mixed with HEPA filtered air and introduced into the chamber.  The MS2 aerosol 
solution was placed on an automated rocker platform (Maddell ZD-9550) and supplied to 
the aerosol generator described above.  The rocker and aerosol generator are shown in  
Figure 10 and Figure 11.  MS2 solution was supplied to the aerosol generator at a rate of 
1 ml/min when additional aerosol injection was triggered by the Grimm measurements. 
 
 
Figure 10: Rocker Platform 
 
 
 
Figure 11: Aerosol Generator 
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Maintenance of Viral Aerosol Concentration 
Aerosol particle concentrations were monitored using a Grimm optical particle counter.  
A target concentration for each level of viral load was specified by Dycor.  These levels 
were extrapolated using data from prior exposures conducted in the exposure chamber.  
MS2 aerosol regeneration was provided via automatic injection, when the particle count 
dropped below the target concentration level.  Particle counting during the five minute air 
purge was controlled in a similar fashion and continued until the Grimm optical particle 
counter registered a sustained particle concentration of less than 1 particle (0.5 to 2.0 
microns in size) per 0.12 liters of air.     
 
Final Determination of Aerosol Concentration 
Final aerosol concentration was determined using slit to agar plaque count.  Two slit to 
agar biological air samplers, model number STA-203 manufactured by New Brunswick 
Scientific, were employed for this purpose.  These slit to agar samplers operated at a flow 
rate of 30 lpm.  The slit to agar samplers were operated for two minutes per plate during 
the high and moderate viral load trials and for five minutes per plate during the low viral 
load trials and for the chamber blanks.  Multiple plates were necessary during the high 
and moderate viral load conditions to allow the plates to be counted after incubation.  
Excessive exposure on a single plate would result in a “too numerous to count” (TNTC) 
result that would invalidate the plate count.     
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Equipment Preparation 
Preparation of Collection Media 
Remel MicroTest M5 Multi-Microbe Media (Remel M5) was selected as the collection 
media for all instruments in this study.  Remel M5 is commercially available in three 
milliliter vials only, thus requiring multiple three ml vials to be combined in order to 
produce the lot sizes required for the sampling equipment.  Prior studies conducted by 
USAFSAM noted excessive foaming when Remel M5 was used in an impinger collection 
system due to turbulence produced in the media.  This foaming was partially addressed 
by the addition of 0.1% anti-foam, Y-30 aqueous emulsion, manufactured by Sigma 
Aldridge, to the media.  This was done after the Remel M5 had been combined into 40 
milliliter lots by adding 40 microliters of anti-foam to each lot.  Remel M5 with anti-
foam was used as the collection media for all samples, including for the preservation of 
DFU-1000 sample filters.  Use of similar collection media for all applications eliminated 
the variability that would have been introduced by the use of multiple media types.     
 
Preparation of XMX/2L-MIL 
XMX/2L-MIL canister components were sterilized overnight in an autoclave prior to 
each day of sampling.  Removal of contamination was verified by swabbing each canister 
prior to use.  Swabs were taken around the air flow points of each canister.  The canister 
assembly was then inserted into the XMX/2L-MIL per manufacturer instructions.  In 
order to further reduce the foaming of the Remel M5 observed in prior testing, a flow 
reducer was designed by Dycor for USAFSAM.  This flow reducer consists of a brass 
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cylinder with a small hole that is placed between the liquid impingement module and the 
fluid trap to reduce secondary flow into the impinger module.  This reduces airflow into 
the collection media from approximately 12.5 lpm to 4 lpm and reduces the agitation and 
evaporation of the collection media (Bliss, 2009).   
The XMX/2L-MIL was prepared with an expendable impinger nozzle for each test per 
the manufacturer’s instruction.  A 50 milliliter sample collection tube was filled with 5 
milliliters of Remel M5 media.  This was then inserted into the XMX/2L-MIL per the 
manufacturer’s instructions.  The liquid impinger module of the XMX/2L-MIL is shown 
in Figure 12. 
 
      
Figure 12: XMX Impinger Module Shown Without Tube (Left) and With Tube (Right)         
   
 
Preparation of DFU-1000 
The DFU-1000 was prepared according to Air Force Technical Order 11H1-11-2 using a 
standard sampling expendables kit.  A new expendables kit was used for every sample 
trial and includes 3 filters (1 spare), 2 pairs of latex gloves, 1 pipette, plastic whirl bags, 
paraffin film, and a zip-lock bag.  The kit and its contents are shown in Figure 13.       
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Figure 13: DFU Sampling Kit Contents 
 
 
The filter cartridges were then inserted into the intake module and attached to the pump 
module and casing.  The DFU-1000 filter cartridges and intake module are shown in 
Figure 14. 
 
        
     Figure 14: DFU Filter Cartridge (Left) and Intake Module (Right) 
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Test Cycles 
XMX/2L-MIL Decontamination Trials 
Two test days were devoted to the evaluation of field decontamination effectiveness 
following XMX/2L-MIL exposure to viral agent during sampling.  Each of these sample 
days consisted of an initial swabbing to verify absence of contamination, five minutes of 
sampling during exposure to a purged or “clean” chamber, five minutes of sampling 
under high levels of viral load, decontamination using hypochlorite solution, a 15 minute 
air purge, and five minutes of sampling from a purged chamber following air purge.  
Three XMX/2L-MIL high volume air samplers were simultaneously operated during 
these trials.  Sampling data obtained from these XMX/2L-MIL decontamination trial days 
is included in this study only for evaluating response variability among multiple 
XMX/2L-MIL air samplers.   
 
Comparison Trials 
Three test days were allocated to the comparison of the XMX/2L-MIL and the DFU-
1000.  One day was allotted for studies under each level (High, Medium, and Low) of 
viral load.  For each sampling day, two, five minute chamber exposures to the appropriate 
level of viral load were made for each high volume sampler.  For each five minute 
exposure period sampling using an AGI-30, and Biosampler was included as well.  
Additionally,  five minutes of sampling with the XMX/2L-MIL and DFU-1000 were 
completed for two chamber blanks each day.  Decontamination evaluation was 
accomplished during these test days, as well, and is discussed in the “Decontamination 
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comparison” section.  A complete test matrix for the comparison trials is included in 
Appendix 1.       
 
Retrieval and Preparation of Sample 
AGI-30 and SKC Biosampler 
After each viral exposure run, collection media from the Biosampler and AGI-30 was 
removed from the impinger assembly and transferred to a 50 ml collection tube.  A final 
volume of sample was measured and recorded for each sample.  An example of the 50 ml 
collection tubes used for all equipment throughout the study is shown in Figure 15 
 
 
Figure 15: 50 ml Conical Collection Tube 
 (From Lawrence, 2003) 
 
XMX/2L-MIL 
Following each test run, the expendable impinger tube was discarded and the 50 ml 
sample tube removed from the impinger module.  Standard laboratory practices were 
followed to ensure that any MS2 contamination present on the XMX/2L-MIL unit was 
unable to come in contact with the sample.  Once the sample tube was removed from the 
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XMX/2L-MIL, it was capped, sealed with parafilm and taken to the laboratory for 
analysis by plaque assay.   
 
DFU-1000 
After air sampling was complete, both dry filters were removed from the DFU-1000 filter 
inserts and placed in a 50 ml collection tube with 15 ml of Remel M5 collection media.  
Collection media was allowed to make complete contact with the filter material by hand 
agitating the collection tube.  Once received in the laboratory working area, the filters and 
sample media were vortexed for 10 seconds at a speed of approximately 3200 revolutions 
per minute.  Sample media was then collected for analysis by plaque assay.     
 
Laboratory Analysis 
Preparation and Incubation of Plates 
Differently sized plates were prepared for the plaque assay and STA collection system.  
The plaque assay required 100 mm plates, while the STA required 150 mm plates for the 
slit to agar.  Plaque assay plates were prepared by using 10 ml of MS2 growth media with 
an overlay of 200 µl of E.-coli, ATCC 15597, (8.75 x 108 CFU/ml) and 200 µl of sample, 
or diluted sample, as appropriate.  The overlay was mixed by gently hand swirling the 
prepared plate.  Slit to agar plates were prepared using 25 ml of MS2 growth media, with 
500 µl of E.-coli as an overlay.  This preparation technique for plaque assay plates is 
described by Adams in Bacteriophages (Adams, 1959).  The MS2 growth media 
consisted of 5.6 grams bacto-agar, 6 grams of sodium chloride, 5 grams of proteose 
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peptone, 2 grams of yeast extract, and 5.2 ml of glycerol added to 1 liter of distilled 
water.  After sample was added plates were incubated overnight, for a minimum of 12 
hours, at a temperature of 37 degrees Celsius.     
 
Quantification of Virus in Sample 
Plaque Assay 
Virus quantity was determined through the use of plaque assay.  Plaque assay provides a 
relative quantification of bacteriophage in a sample (Adams, 1959).  Serial dilutions were 
necessary for the proper quantification of these assays.  This was accomplished by 
vortexing the collected sample in the 50 ml collection tube to homogenize the sample.  
Vortexing was accomplished using a Vortex Genie 2 manufactured by Scientific 
Industries, Inc.  Samples were vortexed at a speed of approximately 3200 revolutions per 
minute (RPM). An aliquot of sample (50 µl) was then pipetted into 450 µl of sterile 
Remel M5 media.  The dilution was vortexed for five seconds to homogenize the sample 
with the sterile M5 media.   For further dilutions of 10-2, 10-3, and 10-4, this process was 
repeated until the proper dilution had been achieved.  Figure 16 shows the serial dilution 
process in detail (LaRoche, 2009).    The sample plates referenced above were incubated 
at least 12 hours.  Plaque forming units were counted visually for each plate, as shown in 
Figure 17, and the count was scaled to the proper order of magnitude by dividing the 
count of plaque forming units by the dilution factor.  For example, the number of plaque 
forming units on a 10-3 dilution would be divided by 0.001 to obtain the final count 
present in the undiluted sample.  Once an approximate range of expected plaque forming 
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units per ml of sample was known, a single dilution was plated as opposed to plating each 
of the serial dilutions.  This reduced the time, resources, and manpower required for 
duplicate plating and analysis of multiple dilutions.  Two plaque assay plates were 
prepared for each specified dilution, as well as the undiluted samples. 
 
 
Figure 16: Serial Dilution Procedure     
(Adapted From LaRoche, 2009) 
 
 
 
Figure 17: Visual Counting of Plaque Assay 
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PCR Analysis 
Evaluation of decontamination capabilities to levels below the limits of detection for PCR 
analysis requires that samples be analyzed by PCR equipment used by Air Force 
laboratory personnel during response to a biological incident. Samples were shipped to 
the Applied Technology Center of USAFSAM located at Brooks City-Base, Texas for 
PCR analysis. This analysis was performed for MS2 presence/absence using the JBAIDS 
system.  Reagents, probe, and primer sequences for MS2 are proprietary products 
obtained from Idaho Technologies.  
 
Decontamination Comparison 
Selection of Swab Surfaces for Contamination Detection 
Prior decontamination studies on the XMX/2L-MIL analyzed swabs taken from surfaces 
directly in contact with the sample airflow (LaRoche, 2009).  These surfaces are the 
likely pathways for previous sampling events to contaminate succeeding samples.  The 
virtual impactor of the XMX/2L-MIL consists of the five components shown in Figure 
18, with each having surfaces in direct contact with sample airflow.   
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Figure 18: Components of XMX/2L-MIL Virtual Impaction Module 
A - Primary Inlet, B - Primary Nozzle Plate, C - Upper Canister, D - Lower Canister 
E - Final Nozzle (LaRoche, 2009) 
 
 
 
Similarly, surfaces in direct contact with the sample air flow on the DFU-1000 were 
selected for contamination detection.  These surfaces are located on the air intake housing 
and on the plastic filter inserts and are shown in Figure 19.  After the surfaces were 
swabbed, the swab was placed in 5 ml of Remel M5. 
 
    
Figure 19: Swab Surfaces on DFU-1000      
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Hypochlorite Decontamination 
A decontamination solution was prepared in a 5 gallon container (shop bucket) using 1 
liter of commercially available, 5.25% sodium hypochlorite bleach mixed with 9 liters of 
tap water.  A rinse container was prepared with 10 liters of tap water.   These materials 
were similar to those used in previous decontamination studies on bacterial agents 
conducted by the USAFSAM (LaRoche, 2009).  Each component for both the XMX/2L-
MIL and DFU-1000 was submerged in the container with hypochlorite solution for 5 
minutes.  This was followed by five minutes of submersion in the rinse container.  Each 
component was then hand dried using paper shop towels.  Throughout the 
decontamination process, separate working stations and containers were used for each 
instrument.  This procedure reduced the possibility of cross contamination between 
instruments during the decontamination process.  
 
Post Decontamination Swabbing 
After the completion of the hypochlorite decontamination process and drying, surface 
swabs were taken again using the previously described procedure.  This allowed for the 
quantification of residual surface contamination following decontamination.  Swabs were 
analyzed by vortexing for 10 seconds at approximately 3200 rpm, similar to the filter 
extraction used for the DFU-1000 samples.  This procedure allowed for the extraction of 
MS2 from the swab into the M5 media.  The collection media was then plated using the 
plaque assay technique described earlier.       
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Post Decontamination Air Sample Collection 
To evaluate the extent that MS2 residual from previous sample runs contaminated 
subsequent sample attempts, a 5 minute air sample from a purged chamber was collected 
following the first MS2 exposure and field decontamination for each of the three 
comparison trial days.  This sampling was performed using the 2 XMX/2L-MILs and the 
DFU-1000 used in the MS2 exposure and field decontamination.  Samples were collected 
as described in the previous sections.  
      
Decontamination Station Ambient Air Monitoring 
Results from prior studies evaluating the decontamination of bacterial agents indicated 
the need to monitor for ambient air contamination in the decontamination work stations.  
This is necessary since the decontamination stations at the Dycor facility are co-located 
in the same room as the aerosol test chamber.   This condition creates the potential for 
airborne agent released during the removal of the high volume air samplers to pose a 
contamination risk during portions of the decontamination processes such as drying or 
surface swabbing.  A single XMX/2L-MIL was operated to determine the ambient level 
of MS2 contamination present in the work area.  This XMX/2L-MIL was placed near the 
location of the high volume air sampler test ports on the Dycor exposure chamber.  This 
location was considered representative of a worst case exposure to ambient MS2 
contamination at the location of the decontamination stations.  The decontamination 
stations were located on the opposite side of the test chamber room.  Undiluted plaque 
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assays were prepared to analyze the samples collected from this ambient air sampling for 
MS2. 
 
Data Analysis 
Calculation of Plaque Forming Units in Sample 
Plaque forming units per milliliter of collection media was used to determine the air 
concentration collected by the air sampling system.  First the total PFU collected was 
calculated by multiplying the liquid plaque concentration (PFU/ml) by the total volume 
of collection media remaining after collection was complete.  Use of the remaining 
volume of collection media, as opposed to initial media volume, is particularly important 
for impinger collection systems that tend to lose sample media during sampling.  This 
total PFU collection was then divided by the total air volume sampled during the five 
minute trial.  PFU data for the DFU-1000 and surface swabs were similarly determined, 
except that the volume of media added to the collection swab or filter was the volume 
used as the total media volume.   
 
Particle Size Distribution Analysis 
To determine the extent that the particle size distribution had as a performance factor in 
the effectiveness of the sampling systems, particle size distributions were analyzed for 
similarity using their Count Median Diameter (CMD).  A CMD distribution of 51 six 
second Grimm samples was prepared for each trial.  Comparison of CMD distributions 
between trials was conducted using a Kruskal-Wallis one way ANOVA (K-W ANOVA), 
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with a Dunn’s rank sum post-test when significant differences were identified by the K-
W ANOVA.  Non-parametric comparisons of the median were needed once it was 
determined that an assumption of normality or log-normality could not be made.  This 
determination was made using results from the Kolmogorov-Smirnov test for normality.  
Additionally, non-parametric analysis methods, such as K-W ANOVA, are considered to 
provide a more conservative analysis of variance.  Kruskal-Wallis and Kolmogorov-
Smirnov analysis was performed using Minitab version 15.  The Dunn post-test analysis 
was performed using Prism Graphpad software, version 5.    
 
MS2 Sample Data Analysis 
The small number of samples taken for both the air sampling and decontamination 
comparisons do not allow for the reliable use of parametric statistics for data analysis.  
For a small data set, a determination of normality cannot be made or assumed.  
Additionally a comparison of means is more likely to be influenced by the presence of 
outlying data points.  For these reasons, the non-parametric K-W ANOVA was used for 
the analysis of these results as well.  The Dunn post test was conducted once the K-W 
ANOVA identified significant differences between data sets.        
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IV.  Results and Analysis 
 
Air Sampler Flow Rate 
Flow rate measurements for the XMX/2L-MIL were conducted by Dycor Technologies 
using a proprietary method.  Measurements were made at the exhaust point of each 
instrument after three minutes of operation and 20 minutes of operation.  The results for 
the measurements taken after three minutes of operation are presented in Table 4.   Each 
sample presented in this study was collected for five minutes; therefore, the air flow rate 
at three minutes is considered to be a representative average air flow rate during the five 
minutes of sample collection. 
 
Instrument Temperature 
(Celsius) 
Pressure (kPa) Flow Velocity 
(m/s) 
Flow (slpm) 
XMX 1 46.4 93.49 6.60 667 
XMX 2 42.6 93.43 6.15 620 
XMX 3 44.6 93.42 6.15 620 
XMX 4 43.3 93.42 5.94 599 
DFU 28.3 93.90 7.67 778 
 
Table 4: High Volume Equipment Flow Rate Measurements 
Provided by Dycor Technologies, 2009 
 
 
The measurements provided by Dycor were calculated using a proprietary methodology 
and presented as flow rate in standard liters per minute (SLPM) or air flow at 25 degrees 
Celsius and 101.325 kilopascals (kPa).  These flow rates were then converted to liters per 
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minute using ambient temperature and pressure conditions.  The ambient flow rates for 
each trial are presented in Appendix 4.  Flow rates measured after three minutes of 
operation are used in the remainder of the data analysis.  These ambient flow rates are 
considered to be the most representative measurement of the actual air flow through the 
high volume sampler.  This conversion allows for sample data from the high volume air 
samplers to be compared with data obtained from the low volume air sampling equipment 
on a standardized unit of volume (1 liter) basis.  Flow rates calculated using the Dry-Cal 
for the AGI-30 and SKC Biosampler are presented in Table 5.  These flow rate 
measurements were confirmed before and after each day of air sampling. Both the AGI-
30 and Biosampler act as a critical orifice, thus maintaining constant flow during 
sampling. 
 
Instrument Ambient Flow Rate (lpm) Pump Method Used 
AGI-30 12.75 Vacuum Line 
Biosampler 12.5 Vac-U-Go Sonic Flow 
Pump 
 
Table 5: Low Volume Equipment Flow Rate Measurements 
 
 
 
Particle Analysis of Viral Aerosol in Chamber 
Particle Loading in Chamber 
Particle loading in the chamber was measured by the Grimm Optical Particle Counter and 
was observed to vary widely throughout the five minutes for each trial run.  An example 
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of particle loading variation is shown in Figure 20 below.  Figure 20 shows a time 
elapsed plot of the particle count present in the chamber using 18 second moving 
averages collected from the Grimm OPC. 
 
  
   
Figure 20: Particle Load in Chamber as a Function of Time, Trial 06 
 
 
The results shown in Figure 20 are representative of the variation observed for all trials in 
the particle loading throughout each trial.  A significant drop in aerosol particle 
concentration in the chamber was frequently observed after the air sampling equipment 
began operating for the majority of trials.  This drop in particle concentration 
demonstrates the tendency of high volume air sampling equipment to strip particles from 
the aerosol faster than they can be regenerated.   Chamber particle concentration plots for 
all sample trials are included in Appendix 3  
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Overall Particle Size Distribution during Sample Runs 
Particle size distributions (as dN/dLogDp) for both high and low ACPLA sample runs are 
shown in Figure 21 and Figure 22.  These figures are presented as examples of the 
particle size data recorded by each instrument during an air sampling trial.  Geometric 
mean particle size for each trial run is shown in Table 6.  Geometric mean particle size 
and count median diameter (CMD) are the same for lognormal particle size distributions. 
   
       
Figure 21: Particle Size Distributions for Example High ACPLA Trial 06, ACPLA = 93.2 
 
 
 
 
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
0.3 0.5 0.8 1.6 3 5 10
dN
/d
Lo
gD
p 
(#
 P
ar
ti
cl
es
/c
m
3)
Dp (microns)
GRIMM OPC 
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
0.
5
0.
8
1.
2
1.
8
2.
8
4.
4
6.
7
10
.4
16
.0
dN
/d
Lo
gD
p 
(#
 P
ar
ti
cl
es
/c
m
3)
Dp (Microns)
APS 3321
 
87 
 
     
 
Figure 22: Particle Size Distributions for Example Low ACPLA Trial 18, ACPLA = 9.3 
 
 
 
As shown by both the visual comparison of the particle size distribution plots and by 
comparison of the geometric mean particle size, there is a substantial difference in the 
particle size data reported by the APS 3321 and the Grimm OPC.  This requires that the 
most representative size distribution be selected for further analysis and comparison.   
Particle size distributions plotted using data from the Grimm OPC tend to represent 
smaller particle sizes more than particle size distributions plotted using APS data.  The 
most likely reason for this difference is the particle size sorting limit for each instrument.  
The Grimm OPC has a lower particle size sorting limit of approximately 0.3 microns, 
while the APS has a lower sorting limit of approximately 0.5 microns.  For this reason, 
the Grimm OPC is considered to be the most representative instrument for the evaluation 
of particle size distribution and further analysis will be limited to data obtained from the 
Grimm OPC.    
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Trial ACPLA APS 3321 Geometric Mean Diameter 
(Microns) 
Grimm OPC 
Geometric Mean 
Diameter (Microns) 
TR 06 93.2 3.588 1.410 
TR 09 74.4 3.376 1.227 
TR 18 13.9 1.420 0.489 
TR 21 21.0 2.264 0.588 
TR 25 9.3 N/Aa 0.642 
TR 28 18.4 2.513 0.624 
a Particle size distribution for trial run not collected due to equipment error 
Table 6: Comparison of Geometric Mean Diameter From APS 3321 and Grimm OPC 
 
 
 
 
Comparison of Particle Size Distribution Between Sample Runs 
Count median diameter (CMD) was calculated for each 6-second particle size distribution 
measured using the Grimm optical particle counter.   Particle size distributions between 
sample trial runs were compared using a Kruskal-Wallis one way ANOVA of the count 
median diameters for each 6 second sample.  Six second CMDs for each trial run are 
presented as a in Figure 23 below. 
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Figure 23: Six Second Count Median Diameter (CMD) Measured by Trial Run 
 
 
 
Comparison of particle size between sample runs using a Kruskal-Wallis one-way 
ANOVA (α = 0.05) revealed a significant difference (P < 0.001) in the median CMDs 
between the 6 trial runs.  A Dunn’s rank sum post test identified that the high ACPLA 
median CMDs were significantly different from the low ACPLA median CMDs.  No 
other significant differences, such as CMDs within high ACPLA or within low ACPLA 
trials, were identified.  Median CMD for each trial is shown in Table 7.  
 
 
 
 
 
90 
 
Trial ACPLA Median CMD 
(Microns) 
Range of CMD 
(Microns)  
TR 06 93.2 1.60 0.35 – 5.43 
TR 09 74.4 1.30 0.35 – 5.76 
TR 18 13.9 0.40 0.35 – 1.16 
TR 21 21.0 0.45 0.00a – 3.01 
TR 25 9.3 0.40 0.00a – 2.67 
TR 28 18.4 0.38 0.00a – 4.06 
aNumerous six second samples taken with the Grimm OPC failed to detect particles, therefore a 0.00 CMD 
was used for statistical representation. 
 
Table 7: Comparison of CMD Between Trials 
 
 
 
Comparison of Air Sampling Equipment in the Collection of MS2 Aerosol: 
Performance Comparison of MS2 Collection for all Evaluated Air Sampling Equipment 
Overall results for the collection of aerosolized MS2 bacteriophage as a function of viral 
load present in the chamber are shown in Figure 24.  Viral load in the chamber is 
expressed in terms of agent containing particles per liter of air (ACPLA). 
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Figure 24: MS2 Air Sample Collection Relative to ACPLA Present in Chamber 
 
 
 
As indicated by the results shown in Figure 24, the XMX/2L-MIL was shown to be as 
effective as both low volume air samplers to which it was compared.  A large degree of 
intra-instrument variability was observed in the XMX at high ACPLA levels.  The DFU-
1000 appears to have similar MS2 collection performance to the other evaluated air 
samplers when high ACPLA levels are present.  At lower ACPLA levels, the DFU-1000 
appears to underperform the XMX/2L-MIL, AGI-30, and Biosampler on a concentration 
basis.     
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Several data points are excluded from these presentations including 1 data-point for the 
DFU-1000, 2 data-points for the AGI-30, 2 data-points for the Biosampler, and 1 data-
point from each XMX unit.  Upon initial evaluation of the data from the plaque assays, it 
was apparent that serial dilutions were probably mis-recorded either during the plating 
itself or when the plates were being counted and data assigned to a particular dilution.  
This probable error may have resulted in a shift in the plaque count of an order of 
magnitude from the actual plaque count had the plates been accurately recorded.  A plot 
incorporating all data points is included in Appendix 7, Figure 33.  Plots containing all 
data points corrected to the serial dilution that the author considers to be correct are 
included in Appendix 9. 
 
Air sample results were standardized by the viral load (ACPLA) present in the exposure 
chamber to PFU/liter of air per ACPLA.  This standardization allows for a median MS2 
air sample concentration to be determined using data collected from multiple levels of 
airborne viral load present in the chamber.  Standardized results are presented in Figure 
25. 
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Figure 25: Air Sample Results Standardized to 1 ACPLA of Viral Load     
 
 
                 
The median results and range for each instrument are presented in Table 8.  The reduced 
MS2 collection by the DFU-1000 at lower ACPLA levels significantly decreases the 
median standardized MS2 concentration measured by for the DFU-1000 as shown in 
Table 8.  
 
 
Number of 
Trials Instrument 
Median Sampled MS2 
Concentration per ACPLA 
Present in Chamber                
PFU/(Liter Air*ACPLA) 
Range of Sampled 
Concentration per ACPLA 
Present in Chamber 
PFU/(Liter Air*ACPLA) 
5 XMX 2 43.98 34.33 – 52.50 
5 XMX 3 54.89 21.51 – 79.57 
5 DFU 10.19 2.55 – 31.12 
4 AGI-30 29.39 26.44 – 50.43 
4 Biosampler 30.29 22.78 – 37.14 
 
Table 8: MS2 Collection by Instrument Standardized to 1 ACPLA of Viral Load 
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Comparative analysis between all evaluated samplers using Kruskal-Wallis one way 
ANOVA (α = 0.05) revealed a significant difference (p = 0.009) in the median 
standardized MS2 collection.  A Dunn’s rank sum post test revealed that the standardized 
MS2 collection obtained using the DFU-1000 is significantly different from the MS2 
collection obtained using the XMX/2L-MIL.  This significant difference was found for 
both XMX 2 and XMX 3.  Other comparison results using the Dunn’s post-test reveal no 
significant difference between the XMX/2L-MIL, the AGI-30, or the Biosampler or 
between the DFU-1000 and the AGI-30 or Biosampler.  Kruskal-Wallis one way 
ANOVA results were also performed on the corrected data-set in Appendix 9 and 
confirm the findings of the data analysis presented with the data points excluded.  
 
Quantification Limitations of Air Sampling Instruments  
Low levels of airborne viral load, less than 5 ACPLA, were not successfully produced 
during any of the six trials.  The lowest level of viral load produced was 9.3 ACPLA.  
Plots of MS2 sample collection relative to ACPLA present in chamber for the high 
volume air samplers with linear trendlines are included in Figure 26.  As indicated by the 
linear trendline, the DFU-1000 is unable to reliably deliver quantifiable results at ACPLA 
levels lower than approximately 14 ACPLA.  MS2 collection using the XMX/2L-MIL 
suggests a possible linear relationship relative to ACPLA present in the chamber.  This 
allows the XMX to reliably produce quantifiable results for MS2 collection at the levels 
of airborne viral load evaluated in this project.  The similarity of the linear trendlines for 
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XMX 2 and XMX 3 appear to be caused by chance.  A high degree of variability was 
observed between XMX 2 and XMX 3. 
 
 
 
Figure 26: MS2 Collection by High Volume Air Sampling Equipment with Linear Trendlines 
 
 
 
MS2 sample collection trendlines for low volume sampling equipment are shown in 
Figure 27.  Similar to the XMX/2L-MIL, the AGI-30 and Biosampler produce reliable 
results at all trial ACPLA levels.  This indicates that quantifiable measurements of 
airborne viral load can be obtained using the AGI-30 and Biosampler at the levels of 
airborne MS2 evaluated in the trials presented in this study. 
DFU Linear Fit Eqn.
y = 32.255x - 447.17
R2 = 0.9455
XMX 2 Linear Fit Eqn.
y = 39.267x + 174.46
R2 = 0.8929
XMX 3 Linear Fit Eqn.
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R2 = 0.713
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Figure 27: MS2 Collection by Low Volume Air Sampling Equipment with Linear Trendlines 
 
 
 
PCR Results from Air Sampling 
PCR results for the air sampling are shown in Table 9.  All high volume air sampling 
systems were capable of collecting a sample resulting in PCR detection for MS2.  XMX 2 
produced one false negative PCR result and one inconclusive result during a trial with a 
very high MS2 plaque assay count.  While the Biosampler and AGI-30 were capable of 
collecting an MS2 sample above the detection limits of the JBAIDS in a majority of 
trials, as expected, the low flow rates result in difficulty collecting sufficient MS2 for a 
relatively high proportion of the samples.  This effect was particularly pronounced with 
Biosampler Linear Fit Eqn.
y = 29.913x - 14.584
R2 = 0.9039
AGI-30 Linear Fit Eqn.
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the Biosampler, where only 60 percent of samples resulted in a detection of the presence 
of MS2.   PCR analysis includes one replicate per sample.  An inconclusive result occurs 
in the event of difference between the primary analysis and the replicate.  An absent 
result occurs when the detection threshold is not reached after a large number of PCR 
cycles.  The number of cycles is typically established by the manufacturer, with 45 cycles 
being the typical value used for the JBAIDS.  Raw results from the PCR analysis, 
including the number of cycles required to reach the detection threshold, is included in 
Appendix 2, Table 25.  
 
 
Instrument Number of Trials with PCR 
Analysis 
JBAIDS-PCR Result for MS2 (# 
Present/#Absent/#Inconclusive) 
XMX 2 6 4/1/1 
XMX 3 6 6/0/0 
DFU 6 6/0/0 
AGI-30 5 4/0/1 
Biosampler 5 3/2/0 
 
Table 9: JBAIDS PCR Results for Sample Analysis Following Exposure to MS2 
 
 
 
Intra-instrument Variability for the XMX 
Results for the trials that collected MS2 using 3 XMX/2L-MIL samplers only are 
presented in Table 10.  These results also indicate a large degree of variation between 
multiple XMX/2L-MIL operating in high viral load conditions and confirm the large 
intra-instrument variability found during trials TR06 and TR09. 
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Trial ACPLA MS2 Concentration XMX 1                    
(PFU/Liter of Air) 
MS2 
Concentration 
XMX 2 
(PFU/Liter of Air) 
MS2 
Concentration 
From XMX 3 
(PFU/Liter of Air) 
TR 3 80.8 8109 9597 18879 
TR 13 82.2 3274 3311 2282 
 
Table 10: MS2 Concentration Sampled during High ACPLA XMX/2L-MIL Decontamination Trials 
 
 
 
Comparison of MS2 Collection by XMX Apparatus and Sample Media 
A previous study conducted by Dycor Technologies collected MS2 bacteriophage using 
an unmodified XMX/2L-MIL with phosphate buffered saline collection media.  As 
previously described, the XMX/2L-MIL systems employed in the current study were 
modified by reducing the air flow to the impinger and by using Remel M5 media instead 
of phosphate buffer solution.  In the previously conducted study by Dycor, five samples 
were collected using a single XMX/2L-MIL over a relatively narrow viral chamber load 
range of 23.0 to 28.1 ACPLA.  The results from this study in PFU/liter of air were 
standardized PFU/liter of air per ACPLA present in the chamber.  This allows for 
comparison with the results from the current study.  The side by side comparison of the 
two studies is shown in Table 11.   
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Instrument Number of Trials 
Median Sampled MS2 
Concentration per ACPLA 
Present in Chamber                
PFU/(Liter Air*ACPLA) 
Range of Sampled 
Concentration per 
ACPLA Present in 
Chamber 
PFU/(Liter Air*ACPLA) 
XMX Dycor (12.5 
lpm secondary 
flow and PBS 
Collection Media) 
5 36.30 32.90 – 38.78 
XMX SAM 
(Secondary Flow 
Reduction and 
Remel M5 
Collection Media) 
10 56.55 37.21 – 79.57 
 
Table 11: Comparison of XMX/2L-MIL using PBS Media and No Secondary Flow Reduction (XMX 
Dycor MS2 Study) with XMX/2L-MIL using Remel M5 Media and Secondary Flow Reduction 
 
 
 
Data analysis using a Kruskal-Wallis one-way ANOVA (α = 0.05) revealed a significant 
difference (p = 0.027) in the MS2 collection effectiveness between the two XMX 
operating methodologies.  Full results from this Kruskal-Wallis one-way ANOVA are 
included in Appendix 6.  These results indicate a significant difference between the two 
sampling apparatuses, but are not able to identify the factors responsible for the 
difference.  Either of the two modifications, or the combination of modifications, could 
have been responsible for the differences in viral collection observed between the two 
studies. 
  
Decontamination Comparison of Air Sampling Equipment 
Decontamination effectiveness for the XMX/2L-MIL and DFU-1000 was evaluated by 
comparing sample results to initial background results and by comparing the degree that 
 
100 
 
contamination was reduced when field decontamination is performed on the XMX/2L-
MIL and DFU-1000. 
   
Comparision of Equipment Field Decontamination Between Air Samples  
As shown in Table 12, residual contamination remaining in air samples taken from a 
purged chamber after decontamination was significantly reduced to levels comparable 
with the initial background levels in the chamber before MS2 was introduced.  The 
residual contamination level detected in the post decontamination was compared to the 
initial background level in the chamber using a Kruskal-Wallis one-way ANOVA (α = 
0.05) and found not to be significantly different for XMX unit 2 (p = 0.268), XMX Unit 3 
(p = 0.077), or the DFU (p = 0.275).  Full results from this ANOVA analysis are included 
in Appendix 6.  The analysis presented here is limited by the small number of trials (n=3) 
with which the comparisons are made.        
 
Instrument Initial Background Median MS2 
Concentration (PFU/Liter of Air) 
Post Decontamination 
Median MS2 Concentration 
(PFU/Liter of Air) 
XMX 2 0.000 0.019 
XMX 3 0.004 0.067 
DFU 0.027 0.009 
 
Table 12: MS2 Air Sample Concentrations Measured using the XMX/2L-MIL and DFU-1000 before 
Exposure (Background) and after Decontamination 
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Median reduction for contamination between sampling events is presented in Table 13 
below.  Raw data for each trial is included in Appendix 5.  A minimum reduction of 
99.9% in MS2 was achieved for each sample run and for all evaluated equipment.  
Percent reduction is obtained by comparing the sample result collected from exposure to 
MS2 in the chamber to the result obtained after sampling in an air purged chamber with 
the decontaminated instrument.   
 
 
Instrument Number of 
Trials 
Median Reduction in MS2 
Contamination % 
Range of Reduction in 
MS2 Contamination % 
XMX 2 3 99.994 99.935 - 99.999 
XMX 3 3 99.999 99.983 - 99.999 
DFU 3 99.999 99.996 – 100.000 
 
Table 13: Reduction in MS2 Contamination between Air Samples Measured by Plaque Assay 
 
 
 
Raw data, including results from the plaque assay, from which the mean reduction was 
generated is included in Appendix 5.  Analysis conducted with a Kruskal-Wallis 
ANOVA (α = 0.05) established no significant difference (p = 0.304) in the median 
reduction of MS2 decontamination obtained from the two XMX/2L-MIL and the DFU-
1000 indicating that both instruments can be sufficiently decontaminated with 
hypochlorite bleach.  The results from this Kruskal-Wallis ANOVA are shown in 
Appendix 6.  PCR results for analysis with the JBAIDS are presented in Table 14.   
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Instrument Number 
of Trials 
Post-Exposure Sample JBAIDS 
Results  
#Present/#Absent/#Inconclusive 
Post-Decontamination Sample 
JBAIDS Results 
#Present/#Absent/#Inconclusive 
XMX 2 3 3/0/0 0/2/1 
XMX 3 3 3/0/0 0/3/0 
DFU 3 3/0/0 0/3/0 
 
Table 14: Evaluation of MS2 Contamination between Air Samples by JBAIDS-PCR Analysis 
 
 
 
Effective reduction of residual contamination between air samples to levels below the 
detection limits of the JBAIDS was observed for both the DFU-1000 and XMX/2L-MIL.  
One post-decontamination sample was inconclusive for the presence of MS2.    
 
Comparison of Surface Removal of Decontamination 
Mean reduction in surface contamination is shown in Table 15, with data for individual 
trials included in Appendix 5.   The mean reduction in surface decontamination for the 
DFU-1000 was very similar to the mean reductions observed for the XMX/2L-MIL.  
Analysis using Kruskal-Wallis one-way ANOVA (α = 0.05) revealed no significant 
difference (p = 0.209) between the DFU-1000 and XMX/2L-MIL in mean reduction of 
MS2 surface contamination after decontamination with hypochlorite.  The range of 
values for mean reduction in surface contamination for the DFU-1000 is slightly higher 
than reductions observed in the XMX/2L-MIL, however.   
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Instrument Number of Trials 
Median Reduction in 
MS2 Contamination % 
Range of 
Decontamination % 
XMX 2 5 99.589 99.091 - 99.966 
XMX 3 5 99.615 99.583 - 99.999 
DFU 4 99.702 97.753 – 99.711 
 
Table 15: Reduction in Surface Contamination Measured by Plaque Assay 
 
 
 
Similar to the results obtained in the evaluation of residual contamination between air 
samples, surface decontamination was also reduced to a level below the JBAIDS limit of 
detection.  These results are shown in Table 16 below.  Pre-decontamination detection of 
surface MS2 contamination was shown to be inconsistent with several samples showing 
absence for MS2 or inconclusive results.  Possible explanations for these false negative 
results are explained in the discussion section.  All samples and duplicates for post-
decontamination samples were found to be absent of surface contamination with MS2.  
Complete laboratory results from the JBAIDS-PCR analysis, including cycles required to 
reach detection threshold, are included in Appendix 2, Table 25.  
 
Instrument Number 
of Trials 
Post-Exposure Surface Sample 
JBAIDS Result  
#Present/#Absent/#Inconclusive 
Post-Decontamination Surface 
Sample JBAIDS Result 
#Present/#Absent/#Inconclusive 
XMX 2 6 4/2/0 0/6/0 
XMX 3 6 5/0/1 0/6/0 
DFU 5 2/2/1 0/5/0 
 
Table 16: Evaluation of Surface Contamination by JBAIDS-PCR Analysis 
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Background Contamination in Work Area 
Results for the XMX/2L-MIL air samples taken in the decontamination work area are 
included as a daily average in Table 17.  Four 30 minute samples were collected each day 
during the time periods in which the equipment was removed from the chamber, 
decontaminated, swabbed, and prepared for the next sample being collected.  A single 
spike in the number of plaque forming units was noted in the final sample taken on 30 
July 2009.  As with the air samples collected inside the exposure chamber, results are 
reported as PFU/Liter of Air and as a daily average. 
   
Date Mean MS Air Concentration in 
Work Area (PFU/Liter of Air) 
Range of MS Air 
Concentration in Work 
Area (PFU/Liter of Air) 
28 July 09 0.008 0.006 – 0.009 
30 July 09 0.021 0.003 – 0.058 
31 July 09 0.006 0.004 – 0.009 
 
Table 17: MS2 Air Sample Concentration in Work Area 
 
 
 
The airborne concentration of MS2 in the work area was very low.  These results from 
the plaque assay are also supported by PCR analysis of the work area samples.  Of the 12 
samples collected in the work area and analyzed by JBAIDS-PCR, 11 failed to detect the 
presence of MS2 and one sample was inconclusive for the presence of MS2.  The 
inconclusive sample was taken on 30 July 2009 and corresponded to the highest sample 
concentration detected by plaque assay out of the 12 samples taken in work area.  Based 
on these results, some contamination could have potentially entered the work area from 
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the chamber on 30 Jul 2009; however, any impact on post-decontamination sample 
results appears to be negligible.    
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V. Discussion and Conclusions 
 
 
Discussion Overview 
This thesis comparatively evaluated the performance of currently inventoried high 
volume air sampling equipment in response to a surrogate viral agent, MS2 
bacteriophage.  Criteria evaluated included overall effectiveness of virus recovery over a 
range of airborne agent concentrations and the decontamination characteristics of the 
equipment using methods available during fielded operations.  Overall limitations of this 
research included: the inability to achieve low agent concentrations representative of 
minimally infectious doses, the relatively small number of samples collected, the limited 
variation of environmental conditions evaluated, and the inherent limitations in the use of 
a surrogate viral agent.  
 
Aerosolized MS2 Collection by Instrument 
Comparison of MS2 Collection by High Volume Collection Systems 
This study demonstrated that the XMX/2L-MIL was capable of significantly (p = 0.009) 
greater collection of MS2 than the DFU-1000 under the sampling conditions evaluated 
for low ACPLA conditions.  The collection of MS2 bacteriophage by the XMX/2L-MIL 
was also statistically similar to the AGI-30 and SKC Biosampler.  Previous studies, such 
as the Indian smallpox study during the 1960’s conducted by Downie, demonstrated that 
methods employing dry media recovered less viable virus than liquid collection methods 
(Downie, 1965).  Tseng et al. also demonstrated significantly higher relative recoveries of 
aerosolized MS2 using a liquid collection method, the AGI-30, than the relative recovery 
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obtained using dry nuclepore filters (Tseng & Li, 2005).   Therefore, it was not surprising 
that the overall collection was significantly less for high volume sampling methods 
employing dry media than high volume methods employing liquid collection.   One 
interesting finding in this study was the large variation in collection effectiveness of the 
DFU-1000 relative to different levels of MS2 concentration in the chamber.  The DFU-
1000, on a per unit of air volume basis, demonstrated similar viable collection 
performance at higher ACPLA to the XMX/2L-MIL.  At lower ACPLA, the DFU-1000 
significantly underperformed compared to the XMX/2L-MIL.  This finding demonstrates 
the potential that recovery of viable viral agent from dry media is more limited by the 
separation of the collected agent from the media than from the actual maintenance of 
viable agent on the filter during sampling.  These suggestions are discussed further in 
other areas of this section.  Relatively low air concentration levels would be expected 
during a response to a viral agent and this study demonstrates that the XMX/2L-MIL 
would likely outperform the DFU-1000 under such conditions.  The linear regression of 
the plaque assay results for the MS2 collected by the DFU-1000 suggests that MS2 
concentrations could not reliably be quantified at levels below 14 ACPLA.  The 
XMX/2L-MIL and the DFU-1000 both recovered detectable quantities of viable MS2 
bacteriophage at all evaluated concentrations of MS2 containing particles.  This was 
further confirmed by the JBAIDS-PCR analysis of the collected samples, which mostly 
reported detectable results for MS2 samples taken during the trials.  Interestingly, one of 
the XMX/2L-MIL systems, XMX 2, produced one sample that failed to detect MS2 and 
one inconclusive sample for MS2 when analyzed with the JBAIDS-PCR.  These results 
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occurred despite very high viable MS2 concentrations for these samples when analyzed 
using plaque assay.  This non-detect result would be considered a false negative result for 
the JBAIDS-PCR analysis and there are several explanations for this occurrence.  First, 
as stated earlier, the JBAIDS analysis was performed at Brooks City Base, Texas, which 
required significant transit times.  These transit times were particularly long, up to 16 
days, from the time that the samples were actually collected.  The effect that these longer 
hold times would have had on the integrity of viral RNA in the sample is not known.  
Second, the sensitivity of the JBAIDS, as reported by Wilson varies among different viral 
agents with some viral agents having sensitivities as low as 78.5 percent.   The sensitivity 
of the JBAIDS for non-pathogenic surrogates, such as MS2 is unknown, but this could 
explain the occurrence of a false negative like that observed here.  Third, technical error 
during laboratory analysis could also result in a false negative.  For example, during 
analysis the technician may have failed to place the extracted RNA into the capillary tube 
for analysis (Escamilla, 2009).  Although a technical error such as this would be rare, 
such an error could nonetheless explain a false negative in both the primary and duplicate 
sample.  Technical laboratory errors, such as those mentioned above, could indicate the 
need to take duplicate air samples for each area during a response.  Collecting and 
analyzing duplicate samples would increase confidence that a negative result obtained 
from the laboratory is truly a negative result.         
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Comparison of High Volume Liquid Collection to Low Volume Liquid Collection 
This study demonstrated similar collection performance between the XMX/2L-MIL high 
volume liquid collection method and both of the low volume liquid collection methods.  
However, several limitations in applying the results of the AGI-30 for MS2 collection 
must be noted in this discussion that could have underrepresented the reported results.  
First, during the analysis of the AGI-30 samples, serial dilutions were only performed to 
a factor of 10-1.  This resulted in a plate count that was TNTC for one of the samples, trial 
run 06, taken during a high ACPLA trial.  Results were reported in the data analysis at 
the minimum threshold at which a TNTC result is obtained.  These results could 
significantly underestimate the actual collection of MS2 by the AGI-30.  Secondly, the 
excessive foaming by the Remel M5 collection media resulted in a significant loss of 
sample during collection.  Including a liquid trap, similar to the Erlenmeyer flask used for 
the Biosampler apparatus, between the sampler and the hose could have prevented this 
problem.  Since a trap was not included in the AGI-30 apparatus, there was no way to 
prevent sample loss, and MS2 collection by the AGI-30 may be underreported as a result.  
The XMX/2L-MIL demonstrated a large degree of variability between the two 
instruments at high MS2 containing particle concentrations.  This large degree of 
variability was also confirmed during the trials in which three XMX/2L-MIL systems 
were exposed to a high concentration of MS2 containing particles for the purposes of 
evaluating viral decontamination methods.  Variability between different XMX/2L-MIL 
systems was also noted by LaRoche during trials involving collection of bacterial agents.  
This large degree of variability could be a significant limitation if the XMX/2L-MIL 
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were used in a situation where quantification of high concentrations of viral agent was the 
goal.  LaRoche also attributed observed XMX/2L-MIL variation to inconsistent mixing 
within the exposure chamber.  Since the same exposure chamber used by LaRoche was 
used for this study, similar mixing inconsistencies may have occurred in these trials as 
well.  High concentrations such as those created during the high agent concentration trials 
are very unlikely during a response to an environmental release of a viral agent or as a 
consequence from a natural disease outbreak.  Intra-instrument variability cannot be 
assessed for the DFU-1000, AGI-30, or Biosampler since multiple samplers were only 
included in this study for the XMX/2L-MIL.  Variability may have an important impact 
on the performance of these other sampling systems as well.  Future studies should 
include multiple simultaneous trials of all equipment being evaluated to fully consider the 
effect of intra-instrument variability on system performance.               
 
Factors Impacting Air Sampling Performance   
The particle size analysis between the high particle concentration trials and the low 
particle concentration trials revealed a significant difference in the count median diameter 
of the MS2 test aerosols.  Each air sampling system has a specific collection efficiency 
that varies by particle size.  As shown in chapter two, detailed information on collection 
efficiency is available for the XMX/2L-MIL, the AGI-30, and the Biosampler.  Only 
limited information was available for the DFU-1000.  Collection efficiencies for the AGI-
30 and Biosampler were extrapolated using data from a study conducted by Willeke 
comparing the capture efficiencies of low volume air sampling methods (Willeke, 
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Xuejun, & Grinshpun, 1998).  Table 18 and Table 19 show  theoretical particle capture 
for the XMX/2L-MIL, AGI-30, and Biosampler for high and low ACPLA trials.  The 
example trials used in this comparison are TR06 for the high ACPLA run and TR18 for 
the low ACPLA run.  These theoretical particle capture tables were generated using 
particle size distributions measured by the Grimm optical particle counter for the entire 
trial period of 5 minutes and reflect the particles counted from a 6 liter aggregate sample.    
 
Particle 
Size Range 
(Microns)  
Total Particles in 
Size Range                      
(#Particles/Liter) 
XMX/2L-MIL 
Theoretical 
Particle Collection 
(# Particles/Liter) 
Biosampler 
Theoretical 
Particle Collection 
(# Particles/Liter) 
AGI-30 
Theoretical 
Particle Collection 
(# Particles/Liter) 
0.3 – 2.0 960 134 844 745 
2.0 – 4.0 383 280 365 364 
4.0 – 7.5 334 234 316 316 
7.5 - 20 8 2 7 7 
Total 1685 650 1532 1432 
 
Table 18: Theoretical Particle Collection by Sampling System for High ACPLA Trial 
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Particle 
Size Range 
(Microns)  
Total Particles in 
Size Range                      
(#Particles/Liter) 
XMX/2L-MIL 
Theoretical 
Particle Collection 
(# Particles/Liter) 
Biosampler 
Theoretical 
Particle Collection 
(# Particles/Liter) 
AGI-30 
Theoretical 
Particle 
Collection (# 
Particles/Liter) 
0.3 – 2.0 793 41 659 568 
2.0 – 4.0 42 30 41 40 
4.0 – 7.5 10 6 10 10 
7.5 - 20 0 0 0 0 
Total 845 77 710 618 
 
Table 19: Theoretical Collection by Sampling System for Low ACPLA Trial 
 
 
 
More detailed information on the XMX/2L-MIL particle collection efficiency for the 
high and low ACPLA trials is available through the USAFSAM.  XMX/2L-MIL 
collection efficiency for particles less than 1 micron in size was not available.  The 
theoretical particle capture presented in Table 18 and Table 19, assumes a low collection 
efficiency of 3 percent for these small particles.  As discussed in chapter two, the AGI-30 
and Biosampler have superior particle size capture efficiencies when compared with the 
XMX/2L-MIL for all particle sizes up to 20 micrometers.  These collection efficiencies 
and the theoretical particle captures shown in Table 18 and Table 19 indicate that the 
XMX/2L-MIL would be expected to have significantly lower collection performance if 
particle capture is the primary contributing factor to viable virus recovery.  The capture 
efficiencies used for Table 18 and Table 19 were determined using an unmodified 
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XMX/2L-MIL with either phosphate buffered solution or sterile water as the collection 
media.  The modifications made to the XMX/2L-MIL for viral collection in this study 
included lowering the flow rate into the liquid impinger and the use of Remel M5 media.  
As discussed, flow rates into the impinger were reduced from approximately 12.5 lpm to 
approximately 4 lpm.  Previous studies conducted by Hogan, as discussed in chapter two, 
address the effect of flow reduction on impinger collection efficiency.  These studies 
indicate that significantly lowering the air flow rate into the impinger significantly 
reduces the collection efficiency.  Lowering the flow rate of the AGI-30 and Biosampler 
from 12.5 lpm to 4 lpm reduced the observed particle collection efficiency for 0.3 
micrometer particles by approximately 80 percent (Hogan, 2005).   Similar effects should 
be expected for the impinger module on the XMX/2L-MIL.  For these reasons, particle 
collection efficiency using the modified XMX/2L-MIL is an unlikely cause of the high 
performance in comparison to the low volume sampling methods observed in this study.  
Particle collection for the DFU-1000 filters were described by Lawrence as being very 
efficient for particle collection as low as 0.1 micron in size; however, as described in 
chapter two, the conditions under which this reported efficiency was determined are 
unknown.  Therefore, the effect that the smaller particle size distributions in the low 
concentration trials had on the performance of the DFU-1000 cannot be assessed.  Other 
factors potentially leading to the observed MS2 collection performance of the XMX/2L-
MIL could include the effect that decreased foaming may have on MS2 activity.  The 
excessive foaming observed in the AGI-30, when Remel M5 was used as the collection 
media, may have significantly lowered the culturable virus recovered in the sample.  
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While these observed turbulence effects were significantly lower for the Biosampler, 
increased foaming from using Remel M5 without flow reduction may have reduced MS2 
activity in the samples collected using the Biosampler as well.  Further studies should be 
conducted to determine the particle capture efficiency for the modified XMX/2L-MIL, 
the AGI-30, and the Biosampler with Remel M5 collection media.  Use of quantitative 
PCR analysis techniques in future studies could possibly determine the impact, if any, 
that increased foaming has on the viability of MS2 in liquid media.  Finally, while the 
AGI-30 and Biosampler have remarkably better particle collection for small particle 
sizes, these smaller particles may contribute less to the total quantity of viable MS2 in the 
aerosol.  Small particles would dry significantly faster than larger particles, thus exposing 
the virus in the particles more to the environmental factors in the chamber.  This drying 
of liquid viral containing particles was described by Verreault and discussed in chapter 
two.  If the larger particles present in the test aerosols contained a significantly larger 
proportion of viable MS2, this could explain the high performance of the XMX/2L-MIL. 
 
Ambient Conditions and Air Sampling Performance 
As discussed in chapter three, ambient conditions including relative humidity and 
temperature were kept relatively consistent between trials.  The relative humidity levels 
of 30 to 32% percent would not be expected to significantly impact the activity of the 
aerosolized MS2.  This was deomonstrated in studies conducted by Dubovi et al., 
showing that MS2 collection using an AGI-30 was not affected by variations in relative 
humidity when the MS2 was suspended in a tryptone broth.  The Luria broth used for the 
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MS2 aerosol solution in this study contains tryptone in similar amounts to the broth used 
by Dubovi.  The Dubovi study suggests that changes in relative humidity would not be 
expected to significantly impact the collection of our MS2 test aerosol using liquid 
collection methodologies.  Similar suggestions about the effect of relative humidity on 
the collection of MS2 aerosol using the DFU-1000 cannot be made, however.  Further 
studies should determine if significant changes in relative humidity can effect the 
collection of MS2 viral aerosol by either the DFU-1000, XMX/2L-MIL or any other 
system under consideration by the Air Force. 
 
Surrogate Virus Use and Sampler Performance 
As discussed in chapter two, the use of surrogate virus in aerosol studies cannot be used 
to precisely predict the behavior of aerosolized viruses capable of human pathogenesis.    
This study, therefore, can only be accurately used to predict the effectiveness of the 
collection of MS2 aerosol in a controlled environment.  Further studies should compare 
collection of other aerosolized viral surrogates and, if possible, live viral agents.     
 
Media Selection and Sampler Performance     
As demonstrated by Hermann and discussed in chapter two, collection media for liquid 
impinger sampling systems can have a significant influence on overall collection 
performance.  The results from this study showed that the Remel M5 media used in an 
XMX/2L-MIL with impinger flow reduction was very capable at collecting aerosolized 
MS2.  While a statistically significant difference in MS2 collection between the modified 
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XMX/2L-MIL apparatus used in the study and the fielded XMX/2L-MIL configuration 
was shown, there are several limitations to this comparison.  First, the significance of the 
individual modifications within the systems cannot be assessed.  Either the reduction in 
flow rate to the liquid impinger or the use of Remel M5 media instead of PBS solution 
could have been responsible for the increased MS2 collection.  Second, the previous 
work conducted by Dycor evaluated the collection of MS2 by the XMX/2L-MIL over a 
very narrow ACPLA range.  The results from this study were obtained over a wide range 
of ACPLA in the chamber.  Although results were standardized by the ACPLA present, 
some difference may be attributable to the variation in ACPLA between the two studies, 
such as the difference in particle size distribution discussed previously.  Future studies 
should assess the performance of collection media through independent, simultaneous, 
and side by side evaluations.   
 
DFU-1000 Performance 
The two most likely causes of the relatively low MS2 collection by the DFU-1000 at low 
to moderate ACPLA levels are problems with filter extraction and desiccation, or drying 
of the MS2 during collection.  While desiccation of the collected MS2 may significantly 
contribute to a reduction in MS2 viability, this would be expected for both high ACPLA 
trials and low ACPLA trials.  The only difference between collection of MS2 during high 
and low ACPLA trials is the amount of collected MS2 on the filter.   The presence of 
additional MS2 on the filter would not be expected to preserve the viability of the MS2 
from the desiccation caused by the rapid flow of air over the filter.  Therefore, filter 
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extraction is left as the most likely contributor to significantly reduced DFU-1000 
performance at lower ACPLA levels.  As discussed in chapter 2, relative recovery of 
MS2 from a filter significantly increases when large amounts of MS2 are seeded on the 
filter as compared with more moderate amounts. 
 
Decontamination 
The field use of 10 percent sodium hypochlorite bleach was shown to have similar 
effectiveness for the decontamination of the XMX/2L-MIL and the DFU-1000.  This 
comparison is applicable for both surface decontamination and for reduction in residual 
contamination between air samples.  As expected, decontamination of viral agents was 
shown to be more effective than the decontamination of bacterial agents conducted by 
LaRoche.  This observation also confirms previous studies demonstrating the greater 
susceptibility of viral agents to decontamination than spore-forming bacterial agents.  The 
results of this study demonstrate that both the XMX/2L-MIL and DFU-1000 can be used 
to obtain multiple samples for JBAIDS-PCR analysis in response to a viral agent.  
Further enhancements to the bleach solution, such as the reduction of the pH as suggested 
by LaRoche, are not necessary to properly decontaminate the equipment after exposure to 
viral agents.  Furthermore, while only a single viral surrogate was used to compare the 
decontamination characteristics of the equipment, non-enveloped viruses are more 
resistant to decontamination than enveloped viruses.  It would be expected that the 
decontamination characteristics for other viral agents on both the XMX/2L-MIL and the 
DFU-1000 would be similar to or better than those observed in this study. 
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Recommendations 
Laboratory Evaluation of Air Sampling Equipment  
Further acquisition of commercially produced biological detection equipment should be 
evaluated independently for all biological agents of interest.  This study shows that a 
reasonable evaluation of air sampling equipment can be performed using a limited 
number of trials in a laboratory environment.  Additionally, acquisition decisions could 
be aided by the implementation of the limited comparison evaluation conducted in this 
study.  
 
Field Use of Existing High Volume Air Sampling Equipment Inventory 
Laboratory evaluation of high volume air sampling equipment demonstrated the 
effectiveness of the equipment in the collection of aerosolized MS2.  This shows that in 
the presence of a sufficient aerosol concentration, both the DFU-1000 and XMX/2L-MIL 
are capable of recovering viral samples for both viable and non-viable analysis.  
Therefore, both the XMX/2L-MIL and DFU-1000 should continue to be used for field 
detection of viral agent in air samples.  This study indicates, however, that the XMX/2L-
MIL should be used, in preference to the DFU-1000, for field uses where relative viable 
quantification of a viral agent is desired.  Since an effective concentration during the 
release of a viral agent would likely be much lower than the concentrations studied in this 
comparison, the XMX/2L-MIL would probably be the best choice to ensure viable 
collection.  Furthermore, if airborne virus concentrations were lower than those used in 
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this study, the XMX/2L-MIL would likely be the best choice for PCR detection as well. 
 
Field use of Hypochlorite Decontamination 
Decontamination using immersion in 10 percent hypochlorite bleach solution is 
recommended for both the XMX/2L-MIL and DFU-1000.  Alterations to the bleach 
solution, such as the adjustment of pH, should not be necessary to adequately 
decontaminate either the XMX/2L-MIL or the DFU-1000 in response to an aerosolized 
viral agent. 
 
Future Research Opportunities 
Evaluation of Future Air Force Air Sampling Equipment Acquisitions 
The Air Force is in the process of considering further additions to the inventory of air 
sampling equipment for biological agents.  One system under consideration is the 
Biocapture 650 manufactured by ICX Technologies: Albuquerque, NM.  Civil 
Engineering Emergency Management has already purchased this system to enhance 
response capability.  Collection performance characteristics for agents of interest have 
not been compared with the existing inventory.   Future studies similar to the work 
presented here could be conducted to evaluate the capabilities and limitations provided by 
this equipment and to determine if the Biocapture 650 is a reliable substitute for the 
existing systems.   Furthermore, future equipment under consideration for purchase 
should be comparatively evaluated with existing inventory to verify the effectiveness of 
new procurements prior to their use as a replacement for existing systems. 
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Limit of Detection for XMX/2L-MIL and DFU-1000 
The results of this current study were unable to determine a limit of detection for MS2 
sampling using the DFU-1000 and the XMX/2L-MIL.  Therefore, the possibility still 
exists for a high false negative rate on both instruments.  Further studies comparing the 
DFU-1000, XMX/2L-MIL and future Air Force system acquisitions at minimally 
achievable aerosol concentrations should be completed.   
 
Evaluation and Optimization of Collection Media 
The importance of sample media selection was shown in this study and by previous 
studies conducted by Hermann.  More definitive studies should be conducted to evaluate 
the application of Remel M5 as a collection media for both low and high volume viral 
aerosol collection.  Furthermore, optimization of sample media should be considered for 
future research.  The Air Force operates in a variety of different environments and 
locations and sample media should be selected and optimized to meet the needs of the 
varied environmental conditions. 
 
Performance Evaluation for Other Agents and Surrogate Agents 
One major limitation of this study is that a single surrogate agent, MS2, was used for the 
evaluation.  The use of MS2, an non-enveloped RNA bacteriophage, was a reasonable 
choice for the initial comparison of air sampling equipment since un-enveloped viruses 
have more resistance to environmental conditions and decontamination.  Some viral 
agents of interest, however, such as Variola and Marburg, are enveloped viruses and may 
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not exhibit similar collection characteristics.  Further research should be conducted using 
multiple viral surrogates to evaluate the applicability and performance of the air sampling 
equipment.      
 
Conclusions 
Comparison of Air Sampling Equipment Effectiveness 
This study evaluated and compared numerous characteristics relevant to the field 
application of high volume air sampling equipment in response to a biological agent.  The 
XMX/2L-MIL modified apparatus used in this study appears to have the most promising 
capability in terms of collection of aerosolized MS2.  This was shown for all ranges of 
ACPLA used in this study.  While the XMX/2L-MIL was shown to be more effective 
than the DFU-1000 in the collection of aerosolized MS2, this study did not provide an 
evaluation of the effectiveness of the XMX/2L-MIL at very low levels of airborne agent 
concentration.  It cannot be inferred from this study that a non-detection result obtained 
from an air sample collected using the XMX/2L-MIL could be used to definitively 
determine the absence of airborne virus following an aerosol release.  A key question 
remains for biological air sampling equipment: What does a result of non-detection really 
mean?  PCR detection was successful on samples collected by the DFU-1000 and 
XMX/2L-MIL for all evaluated concentrations of MS2 in this study; however, lower 
concentrations may not produce reliable detection by the PCR.   Furthermore, this study 
identifies many factors that should be considered throughout the selection and evaluation 
process of biological sampling equipment including selection of surrogate agent, ambient 
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testing conditions, physical aerosol characteristics, equipment alterations, and 
decontamination characteristics.  Each of these characteristics should be considered 
independently in order to fully evaluate any air sampling system.  Finally, minimum 
airborne concentrations of viral agent necessary to obtain quantitative measurements 
from the XMX/2L-MIL cannot be assessed from the results in this project since very low 
levels were not obtained during any of the sample trials.          
 
Comparison of Decontamination Characteristics 
This study demonstrates that decontamination of air sampling equipment by immersion in 
hypochlorite bleach solution is effective for both the XMX/2L-MIL and the DFU-1000.  
The results of this study indicate that both the XMX/2L-MIL and DFU-1000 can be 
properly decontaminated using techniques and materials available in field conditions and 
effectively reused for additional sampling during a response. These findings should 
provide greater confidence to responding personnel in the validity of multiple sample 
results taken using a limited number of collection systems.  The high relative 
performance of hypochlorite decontamination for the XMX/2L-MIL and DFU-1000 does 
not imply that decontamination by hypochlorite should be assumed for all equipment.   
Decontamination should continue to be evaluated as a portion of equipment selection and 
use by the Air Force. 
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Final Considerations 
Biological agents continue to be a key vulnerability in the field response and detection of 
weapons of mass destruction.  Virtually all detection equipment for chemical, nuclear, 
and radiological response has an established limit of detection and a reasonable ability to 
quantify the hazard level for exposed personnel.  The same cannot be said for the 
equipment used in a biological response.  At the same time, biological agents would often 
be the lowest cost choice for a terrorist organization or rogue state intending to use 
unconventional weapons.  This study contributes to the knowledge necessary to 
effectively conduct sampling for a viral agent.  Although limited to a single class of 
biological agent and also limited to the equipment currently used by the Air Force, the 
author hopes that this study will guide the equipment selection for response personnel 
who may face a biological agent head on.  Further work is necessary to increase the 
knowledge and confidence level associated with the use of this equipment.     
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Appendix 1:  Trial Matrix and Schedule 
 
 
 
Table 20: Sample Matrix and Schedule 
 
 
 
 
Date Trial Identification Description Air Sampling Equipment Used
Background 01 XMX Surface Swab 3 XMX 
Background 02 Chamber Background Air Sample 3 XMX
Trial Run 03
MS 2 High ACPLA Air Sample and 
Post MS2 Exposure Swab 3 XMX
Background 04 XMX Surface Swab 2 XMX
Background 05 Chamber Background Air Sample 2 XMX, 1 DFU, 1 AGI-30, 1 Biosampler
Trial Run 06 MS 2 High ACPLA Air Sample 2 XMX, 1 DFU, 1 AGI-30, 1 Biosampler
Trial Run 07 Post MS2 Exposure Surface Swab 2 XMX, 1 DFU
Background 08
Post Decontamination Surface Swab 
and Chamber Background Air 2 XMX, 1 DFU
Trial Run 09 MS 2 High ACPLA Air Sample and 
Post MS2 Exposure Swab
2 XMX, 1 DFU, 1 AGI-30, 1 Biosampler
Trial Run 10 Post Decontamination Surface Swab 2 XMX, 1 DFU
Background 11 XMX Surface Swab 3 XMX 
Background 12 Chamber Background Air Sample 3 XMX
Trial Run 13
MS 2 High ACPLA Air Sample and 
Post MS2 Exposure Swab 3 XMX
Trial Run 14 Post Decontamination Surface Swab 3 XMX
Trial Run 15 15 Minute Air Purge 3 XMX
Background 16 XMX Surface Swab 2 XMX
Background 17 Chamber Background Air Sample 2 XMX, 1 DFU
Trial Run 18
MS 2 High ACPLA Air Sample and 
Post MS2 Exposure Swab 2 XMX, 1 DFU, 1 AGI-30, 1 Biosampler
Trial Run 19 Post Decontamination Surface Swab 2 XMX, 1 DFU
Background 20 Chamber Background Air Sample 2 XMX, 1 DFU
Trial Run 21
MS 2 High ACPLA Air Sample and 
Post MS2 Exposure Swab 2 XMX, 1 DFU, 1 AGI-30, 1 Biosampler
Trial Run 22 Post Decontamination Surface Swab 2 XMX, 1 DFU
Background 23 XMX Surface Swab 2 XMX
Background 24 Chamber Background Air Sample 2 XMX, 1 DFU
Trial Run 25
MS 2 High ACPLA Air Sample and 
Post MS2 Exposure Swab 2 XMX, 1 DFU, 1 AGI-30, 1 Biosampler
Trial Run 26 Post Decontamination Surface Swab 2 XMX, 1 DFU
Background 27 Chamber Background Air Sample 2 XMX, 1 DFU
Trial Run 28
MS 2 High ACPLA Air Sample and 
Post MS2 Exposure Swab 2 XMX, 1 DFU, 1 AGI-30, 1 Biosampler
Trial Run 29 Post Decontamination Surface Swab 2 XMX, 1 DFU
27-Jul
28-Jul
29-Jul
30-Jul
31-Jul
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Appendix 2: Raw Data for Sample Analysis 
 
 
 
Table 21: Calculation of ACPLA by Trial 
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Trial Count a Count b Dilution (1e-X) PFU/mL a PFU/ml b PFU/ml ave
Bkg5 (CT) 1 0 0 5 0 2.5
TR06 (CT)a 301 301 0 1505 1505 1505
TR06 (CT)a 301 301 1 15050 15050 15050
Bkg8 (CT) 1 3 0 5 15 10
TR09 (CT)a 301 301 0 1505 1505 1505
TR09 (CT) 216 240 1 10800 12000 11400
Trial Count a Count b Dilution (1e-X) PFU/mL a PFU/ml b PFU/ml ave
Bkg5 (CT) 3 6 0 15 30 22.5
TR06 (CT)a 301 301 0 1505 1505 1505
TR06 (CT)a 301 301 1 15050 15050 15050
TR06 (CT)a 301 301 2 150500 150500 150500
TR06 (CT) 152 174 3 760000 870000 815000
TR06 (CT) 3 19 4 150000 950000 550000
TR06 (S) 301 301 0 1505 1505 1505
TR07 (S) 3 2 0 15 10 12.5
Bkg8 (CT) 2 3 0 10 15 12.5
TR09 (CT)a 301 301 0 1505 1505 1505
TR09 (CT)a 301 301 1 15050 15050 15050
TR09 (CT)a 301 301 2 150500 150500 150500
TR09 (CT) 85 87 3 425000 435000 430000
TR09 (CT) 6 16 4 300000 800000 550000
TR09 (S)a 301 301 0 1505 1505 1505
TR10 (S) 2 3 0 10 15 12.5
Trial Count a Count b Dilution (1e-X) PFU/mL a PFU/ml b PFU/ml ave
Bkg5 (CT) 2 2 0 10 10 10
TR06 (CT)a 301 301 0 1505 1505 1505
TR06 (CT) 203 223 1 10150 11150 10650
Bkg8 (CT) 0 1 0 0 5 2.5
TR09 (CT)a 301 301 0 1505 1505 1505
TR09 (CT) 130 93 1 6500 4650 5575
Biosampler
DFU-1000
AGI-30
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Table 22: Plate Counts for High ACPLA Trials 
 
Trial Count a Count b Dilution (1e-X) PFU/mL a PFU/ml b PFU/ml ave
Bkg4 (S) 4 6 0 20 30 25
Bkg5 (CT) 4 3 0 20 15 17.5
TR06 (CT)a 301 301 3 1505000 1505000 1505000
TR06 (CT) 77 54 4 3850000 2700000 3275000
TR06 (S) 56 62 2 28000 31000 29500
TR06 (S) 9 9 3 45000 45000 45000
TR07 (S) 2 2 0 10 10 10
Bkg8 (CT) 2 3 0 10 15 12.5
TR09 (CT) 301 286 3 1505000 1430000 1467500
TR09 (CT) 49 56 4 2450000 2800000 2625000
TR09 (S) 38 45 2 19000 22500 20750
TR09 (S) 3 6 3 15000 30000 22500
Trial Count a Count b Dilution (1e-X) PFU/mL a PFU/ml b PFU/ml ave
Bkg4 (S) 1 0 0 5 0 2.5
Bkg5 (CT) 0 2 0 0 10 5
TR06 (CT)a 301 301 3 1505000 1505000 1505000
TR06 (CT) 53 33 4 2650000 1650000 2150000
TR06 (S)b 95 66 2 47500 33000 40250
TR07 (S) 1 2 0 5 10 7.5
Bkg8 (CT) 12 6 0 60 30 45
TR09 (CT) 275 222 3 1375000 1110000 1242500
TR09 (CT) 22 21 4 1100000 1050000 1075000
TR09 (S)b 186 194 2 93000 97000 95000
Trial Count a Count b Dilution (1e-X) PFU/mL a PFU/ml b PFU/ml ave
Bkg16 (S) 1 0 0 5 0 2.5
Sample1 (CT) 1 13 0 5 65 35
Sample2 (CT) 3 6 0 15 30 22.5
Sample3 (CT) 6 7 0 30 35 32.5
Sample4 (CT) 8 6 0 40 30 35
a Sample Plaques were "Too Numerous to Count". 301 was Used as a Representative Value
b Sample was "Replated" 24 hours after Collection due to a Mislabeling of Original Sample Plates
S: Denotes Surface Swab Sample
CT: Denotes Air Sample from "Collection Tube"
XMX - Unit 4
XMX - Unit 3
XMX - Unit 2
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Table 23: Plate Counts for Moderate ACPLA Trials 
Trial Count a Count b Dilution (1e-X) PFU/mL a PFU/mL b PFU/ml ave
TR18 (CT) 34 43 1 1700 2150 1925
TR21 (CT) 111 114 1 5550 5700 5625
Trial Count a Count b Dilution (1e-X) PFU/mL a PFU/mL b PFU/ml ave
Bkg17 (CT) 2 1 0 10 5 7.5
TR18 (CT) 119 117 3 595000 585000 590000
Bkg20 (CT) 0 1 0 0 5 2.5
TR21 (CT) 130 111 2 65000 55500 60250
TR21 (S) 162 184 0 810 920 865
TR22 (S) 1 0 0 5 0 2.5
Trial Count a Count b Dilution (1e-X) PFU/mL a PFU/mL b PFU/ml ave
TR18 (CT) 27 22 1 1350 1100 1225
TR21 (CT) 49 51 1 2450 2550 2500
Trial Count a Count b Dilution (1e-X) PFU/mL a PFU/mL b PFU/ml ave
Bkg16 (S) 6 5 0 30 25 27.5
Bkg17 (CT) 0 0 0 0 0 0
TR18 (CT) 76 80 3 380000 400000 390000
TR18 (S) 104 64 1 5200 3200 4200
TR19 (S) 3 2 0 15 10 12.5
Bkg20 (CT) 1 0 0 5 0 2.5
TR21 (CT) 144 150 3 720000 750000 735000
TR21 (S) 60 52 1 3000 2600 2800
TR22 (S) 5 1 0 25 5 15
Trial Count a Count b Dilution (1e-X) PFU/mL a PFU/mL b PFU/ml ave
Bkg16 (S) 3 3 0 15 15 15
Bkg17 (CT) 0 0 0 0 0 0
TR18 (CT) 87 118 3 435000 590000 512500
TR18 (S) 47 65 1 2350 3250 2800
TR19 (S) 0 2 0 0 10 5
Bkg20 (CT) 0 2 0 0 10 5
TR21 (CT) 168 177 3 840000 885000 862500
TR21 (S) 76 101 1 3800 5050 4425
TR22 (S) 2 1 0 10 5 7.5
Trial Count a Count b Dilution (1e-X) PFU/mL a PFU/mL b PFU/ml ave
Bkg16 (S) 6 5 0 30 25 27.5
Sample1 (CT) 1 4 0 5 20 12.5
Sample2 (CT) 15 13 0 75 65 70
Sample3 (CT) 3 5 0 15 25 20
Sample4 (CT) 50 36 0 250 180 215
Biosampler
XMX - Unit 2
XMX - Unit 3
XMX - Unit 4 Work Area Samples
S: Denotes Surface Swab Sample                 CT: Denotes Air Sample from "Collection Tube"
AGI-30
DFU-1000
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Table 24: Plate Counts for Low ACPLA Trials 
Trial Count a Count b Dilution (1e-X) PFU/mL a PFU/mL b PFU/ml ave
TR25 (CT) 37 51 0 185 255 220
TR28 (CT) 41 53 0 205 265 235
Trial Count a Count b Dilution (1e-X) PFU/mL a PFU/mL b PFU/ml ave
Bkg24 (CT) 1 1 0 5 5 5
TR25 (CT) 16 40 2 8000 20000 14000
TR25 (S) 24 37 0 120 185 152.5
Bkg27 (CT) 0 0 0 0 0 0
TR28 (CT) 21 32 2 10500 16000 13250
TR28 (S) 70 108 0 350 540 445
TR29 (S) 2 2 0 10 10 10
Trial Count a Count b Dilution (1e-X) PFU/mL a PFU/mL b PFU/ml ave
TR25 (CT) 24 23 0 120 115 117.5
TR28 (CT) 28 22 0 140 110 125
Trial Count a Count b Dilution (1e-X) PFU/mL a PFU/mL b PFU/ml ave
Bkg23 (S) 0 0 0 0 0 0
Bkg24 (CT) 0 0 0 0 0 0
TR25 (CT) 55 55 3 275000 275000 275000
TR25 (S) 10 12 1 500 600 550
TR26 (S) 1 1 0 5 5 5
Bkg27 (CT) 32 40 0 160 200 180
TR28 (CT) 81 127 2 40500 63500 52000
TR28 (S) 13 13 1 650 650 650
TR29 (S) 1 0 0 5 0 2.5
Trial Count a Count b Dilution (1e-X) PFU/mL a PFU/mL b PFU/ml ave
Bkg23 (S) 4 1 0 20 5 12.5
Bkg24 (CT) 0 1 0 0 5 2.5
TR25 (CT) 99 100 3 495000 500000 497500
TR25 (S) 9 15 1 450 750 600
TR26 (S) 1 0 0 5 0 2.5
Bkg27 (CT) 9 24 0 45 120 82.5
TR28 (CT) 68 53 2 34000 26500 30250
TR28 (S) 10 14 1 500 700 600
TR29 (S) 1 0 0 5 0 2.5
Trial Count a Count b Dilution (1e-X) PFU/mL a PFU/mL b PFU/ml ave
Bkg23 (S) 0 1 0 0 5 2.5
Sample1 (CT) 6 3 0 30 15 22.5
Sample2 (CT) 6 8 0 30 40 35
Sample3 (CT) 4 2 0 20 10 15
Sample4 (CT) 3 3 0 15 15 15
S: Denotes Surface Swab Sample              CT: Denotes Air Sample From "Collection Tube"
AGI-30
DFU
Biosampler
XMX - Unit 2
XMX - Unit 3
XMX - Unit 4
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Cap # Sample CP
101 101 -Bkg4 U2 Swabs 45.00
101 Repl. Of 101 45.00
102 102 -Bkg4 U3 Swabs 45.00
102 Repl. Of 102 45.00
103 103 -Bkg4 U4 Swabs 45.00
103 Repl. Of 103 45.00
104 104 -Bkg5 U2 CT 45.00
104 Repl. Of 104 45.00
105 105 -Bkg5 U3 CT 45.00
105 Repl. Of 105 45.00
106 106 -TRG U2 CT 29.71
106 Repl. Of 106 29.74
107 107 -TR06 U2 Swabs 34.95
107 Repl. Of 107 35.82
108 108 -TR06 U3 CT 24.58
108 Repl. Of 108 24.58
109 109 -TRG U3 Swabs 32.76
109 Repl. Of 109 32.84
110 110 -Predecon TR06 DFU 37.86
110 Repl. Of 110 45.00
111 111 -Bkg 07 Post decon DFU 45.00
111 Repl. Of 111 45.00
112 112  -Post decon swabs - XMX U2 45.00
112 Repl. Of 112 45.00
113 113 -Post decon 743 Swabs 45.00
113 Repl. Of 113 45.00
114 114 -Bkg 8 U2 CT 45.00
114 Repl. Of 114 45.00
115 115 -Bkg 8 U3 CT 45.00
115 Repl. Of 115 45.00
116 116 - Pre decon DFU TR 09 PM 35.77
116 Repl. Of 116 34.65
117 117 -Post TR9  Bkg DFU Post clean pm 45.00
117 Repl. Of 117 45.00
118 118 -TR9 U2 CT 45.00
118 Repl. Of 118 45.00
119 119 -TR9 U2 Swabs 31.65
119 Repl. Of 119 31.55
120 120 -TR9 U3 CT 24.93
120 Repl. Of 120 25.05
121 121 -TR9 U3 swabs 30.88
121 Repl. Of 121 30.79
122 122 -Post decon 10 U2 Swabs 45.00
122 Repl. Of 122 45.00
123 123 -Post decon 10 U3 Swabs 45.00
123 Repl. Of 123 45.00
124 124 -AGI Bkg 05 45.00
124 Repl. Of 124 45.00
125 125 -AGI TR 06 32.11
125 Repl. Of 125 32.06
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126 126 -AGI Bkg 08 45.00
126 Repl. Of 126 45.00
127 127 -AGI TR09 33.08
127 Repl. Of 127 33.27
128 128 -Biosampler TR06 32.6
128 Repl. Of 128 32.59
129 129 -Biosampler Bkg 05 45.00
129 Repl. Of 129 45.00
130 130 -Biosampler BKg08 45.00
130 Repl. Of 130 45.00
131 131 -Biosampler TR09 32.48
131 Repl. Of 131 32.82
132 132 -DFU Chamber Blank Bkg5 45.00
132 Repl. Of 132 45.00
133 133 -DFU TR6 25.48
133 Repl. Of 133 25.66
134 134 -DFU BKG8  45.00
134 Repl. Of 134 45.00
135 135 -DFU TR09 release 28.61
135 Repl. Of 135 28.64
136 136 -U4 CT1 28July TR 6-10 45.00
136 Repl. Of 136 45.00
137 137 -28july TR6-10 U4 CT2 45.00
137 Repl. Of 137 45.00
138 138 -TR6-10 U4 CT3 45.00
138 Repl. Of 138 45.00
139 139 -28july TR6-10 U4 CT4 45.00
139 Repl. Of 139 45.00
140 140 -BKG 16 U2 Swabs 45.00
140 Repl. Of 140 45.00
141 141 -BKG 16 U3 Swabs 45.00
141 Repl. Of 141 45.00
142 142 -BKG 16 U4 Swabs 45.00
142 Repl. Of 142 45.00
143 143 -BKG 17 U2 CT 45.00
143 Repl. Of 143 45.00
144 144 -BKG 17 U2 CT 45.00
144 Repl. Of 144 45.00
145 145 -TR18 U2 CT 28.52
145 Repl. Of 145 28.62
146 146 -TR18 U2 Swabs 32.88
146 Repl. Of 146 33.67
147 147 -TR18 U3 CT 27.21
147 Repl. Of 147 27.51
148 148 -TR18 U3 Swabs 33.68
148 Repl. Of 148 34.46
149 149 -DFU Bkg 17 45.00
149 Repl. Of 149 45.00
150 150 -DFU TR18 30.46
150 Repl. Of 150 30.31
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151 151 -AGI BKG17 45.00
151 Repl. Of 151 45.00
152 152 -AG1TR18 35.8
152 Repl. Of 152 35.38
153 153 -SKC BKG 17 45.00
153 Repl. Of 153 45.00
154 154 -SKC TR18 35.04
154 Repl. Of 154 35.17
155 155 -PD19 U2 Swabs 45.00
155 Repl. Of 155 45.00
156 156 -PD 19 U3 Swabs 45.00
156 Repl. Of 156 45.00
157 157 -Bkg20 U2 CT 45.00
157 Repl. Of 157 45.00
158 158 -Bkg 20 U3 CT 45.00
158 Repl. Of 158 45.00
159 159 - TR21 U2 CT 28.64
159 Repl. Of 159 28.5
160 160 -TR21 U3 CT 29.28
160 Repl. Of 160 29.19
161 161 -TR21 U2 Swabs 34.00
161 Repl. Of 161 34.72
162 162 -TR21 U3 Swabs 33.12
162 Repl. Of 162 33.05
163 163 -TR21 Pre-decon DFU 30July pm 34.91
163 Repl. Of 163 34.76
164 164 -Post decon 27 (22) 45.00
164 Repl. Of 164 45.00
165 165 -PD 2d U2 Swabs 45.00
165 Repl. Of 165 45.00
166 166 -PD22 U3 Swabs 45.00
166 Repl. Of 166 45.00
167 167 -PD22 U3 Swabs 45.00
167 Repl. Of 167 45.00
168 168 -BKG 20 SKC 38.14
168 Repl. Of 168 40.00
169 169 -BKG 20 AGI 45.00
169 Repl. Of 169 45.00
170 170 -TR21 AGI 36.18
170 Repl. Of 169 45.00
171 171 -DFU Bkg 20 45.00
171 Repl. Of 171 45.00
172 172 -DFU TR21 32.28
172 Repl. Of 172 32.02
173 173 -U4 #1 30Jul 45.00
173 Repl. Of 173 45.00
174 174 -U4 #2 30Jul 45.00
174 Repl. Of 174 45.00
175 175 -U4 #3 30 Jul 45.00
175 Repl. Of 175 45.00
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176 176 -U4 #4 30Jul 40.00
176 Repl. Of 176 45.00
180 180 -Bkg 23 U2 Swabs 45.00
180 Repl. Of 180 45.00
181 181 -Bkg 23 U3 Swabs 45.00
181 Repl. Of 181 45.00
182 182 -Bkg 23 U4 Swabs 45.00
182 Repl. Of 182 45.00
183 183 - TR25 U2 CT 36.37
183 Repl. Of 183 34.44
184 184 - TR25 U3 CT 34.80
184 Repl. Of 184 34.82
185 185 -TR25 U2 Swabs 45.00
185 Repl. Of 185 45.00
186 186 -TR25 U3 Swabs 36.65
186 Repl. Of 186 37.10
187 187 -PD26 U3 Swabs 45.00
187 Repl. Of 187 45.00
188 188 - PD26 U2 Swabs 45.00
188 Repl. Of 188 45.00
189 189 - TR 25 SKC 45.00
189 Repl. Of 189 45.00
191 191 -DFU Post Decon TR25 45.00
191 Repl. Of 191 45.00
192 192 -DFU Pre Decon TR25 37.24
192 Repl. Of 192 45.00
193 193 -DFU 45.00
193 Repl. Of 193 45.00
194 194 -DFU TR25 33.56
194 Repl. Of 194 34.82
195 195 -DFU Bkg 24 45.00
195 Repl. Of 195 45.00
196 196 -BKG 27 U2 CT 36.16
196 Repl. Of 196 45.00
197 197 -BKG 27 U3 CT 45.00
197 Repl. Of 197 45.00
198 198 -TR28 U2 CT 45.00
198 Repl. Of 198 37.45
199 199 -TR28 U3 CT 31.2
199 Repl. Of 199 30.98
200 200 -TR28 U2 Swabs 45.00
200 Repl. Of 200 45.00
201 201 -TR28 U3 Swabs 36.39
201 Repl. Of 201 45.00
202 202 -PO 29 U2 Swabs 45.00
202 Repl. Of 202 45.00
203 203 -PO29 U3 Swabs 45.00
203 Repl. Of 203 45.00
204 204 - AGI TR28 36.8
204 Repl. Of 204 37.00
205 205 -SKC TR28 45.00
205 Repl. Of 205 45.00
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Table 25: JBAIDS PCR Analysis of MS2 Samples (From Applied Technology Center) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
206 206 -DFU TR28 35.8
206 Repl. Of 206 35.89
207 207 -DFU Bkg 27 45.00
207 Repl. Of 207 45.00
208 208 - DFU TR28 swab Pre-Decon 45.00
208 Repl. Of 208 45.00
209 209- DFU TR29 Post-Decon 45.00
209 Repl. Of 209 45.00
210 210 -U4 #4 31July 45.00
210 Repl. Of 210 45.00
211 211 -U4 #3 31July 45.00
211 Repl. Of 211 45.00
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Appendix 3: Particle Loading in Chamber 
(All Plots are 3 Sample, 18 Second Moving Averages) 
 
Figure 28: Particle Load in Chamber as a Function of Time, Trial 09 
 
 
  
Figure 29: Particle Load in Chamber as a Function of Time, Trial 18 
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Figure 30: Particle Load in Chamber as a Function of Time, Trial 21 
 
 
 
 
 
Figure 31: Particle Load in Chamber as a Function of Time, Trial 25 
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Figure 32: Particle Load in Chamber as a Function of Time, Trial 28 
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Appendix 4: Air Sample Comparison Data 
 
 
 
 
 
 
Sample Run Time (min) 5
Q (L/min)
XMX Unit 2 Flow Rate 672
XMX Unit 3 Flow Rate 672
DFU Flow Rate 843
Biosampler Flow Rate 12.5
AGI-30 Flow Rate 12.75
Temp (Deg C) 26
Temp (Deg K) 299
Pressure (kPa) 93.83
Relative Humidity (%) 34.3
Instrument Viral Media Conc. (PFU/ml) Media Vol. Initial Media Vol. Final Air Conc. (PFU/Liter of Air)
XMX Unit 2 2150000 5 5 3199
XMX Unit 3 3275000 5 5 4874
DFU 815000 15 15 2900
SKC 10650 20 18.5 3152
AGI-30a 15050 20 12.5 2951
TR 09 -- High ACPLA (Target ACPLA = 100, Actual ACPLA = 74.4 ) 
Sample Run Time (min) 5
Q (L/min)
XMX Unit 2 Flow Rate 672
XMX Unit 3 Flow Rate 672
DFU Flow Rate 843
Biosampler Flow Rate 12.5
AGI-30 Flow Rate 12.75
Temp (Deg C) 25.7
Temp (Deg K) 298.7
Pressure (kPa) 93.77
Relative Humidity (%) 33.6
Instrument Viral Media Conc (PFU/ml) Media Vol. Initial Media Vol. Final Air Conc. (PFU/Liter of Air)
XMX Unit 2 2625000 5 5 3906
XMX Unit 3 1075000 5 5 1600
DFU 430000 15 15 1530
SKC 5575 20 19 1695
AGI-30 11400 20 11 1967
aPlate was "Too Numerous to Count". Minimum Plate Value of 301 PFU used for Media Conc. and Air Conc.
TR 06 -- High ACPLA (Target ACPLA = 100 , Actual ACPLA =93.2)
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TR 18 -- Moderate ACPLA (Target ACPLA= 10, Actual ACPLA = 13.9) 
Sample Run Time (min) 5
Q (L/min)
XMX Unit 2 Flow Rate 672
XMX Unit 3 Flow Rate 672
DFU Flow Rate 843
Biosampler Flow Rate 12.5
AGI-30 Flow Rate 12.75
Temp (Deg C) 26.6
Temp (Deg K) 299.6
Pressure (kPa) 92.93
Relative Humidity (%) 30.8
ACPLA 13.9
Instrument Viral Media Conc (PFU/ml) Media Vol. Initial Media Vol. Final Air Conc. (PFU/Liter of Air)
XMX Unit 2 390000 5 5 580
XMX Unit 3 512500 5 5 763
DFUb 590000 15 15 2100
SKC 1225 20 19 372
AGI-30 1925 20 12.5 377
TR 21 -- Moderate ACPLA (Target ACPLA = 10, Actual ACPLA = 21) 
Sample Run Time (min) 5
Q (L/min)
XMX Unit 2 Flow Rate 672
XMX Unit 3 Flow Rate 672
DFU Flow Rate 843
Biosampler Flow Rate 12.5
AGI-30 Flow Rate 12.75
Temp (Deg C) 26
Temp (Deg K) 299
Pressure (kPa) 92.92
Relative Humidity (%) 30.5
ACPLA 21
Instrument Viral Media Conc. (PFU/ml) Media Vol. Initial Media Vol. Final Air Conc. (PFU/Liter of Air)
XMX Unit 2 735000 5 5 1094
XMX Unit 3 862500 5 5 1283
DFU 60250 15 15 214
SKC 2500 20 19.5 780
AGI-30 5625 20 12 1059
bPlate Sample Dilution was Recorded One Order of Magnitude too Low. Results Excluded from Analysis
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TR 25-- Low ACPLA (Target = 1 ACPLA, Actual ACPLA = 9.3) 
Sample Run Time (min) 5
Q (L/min)
XMX Unit 2 Flow Rate 672
XMX Unit 3 Flow Rate 672
DFU Flow Rate 843
Biosampler Flow Rate 12.5
AGI-30 Flow Rate 12.75
Temp (Deg C) 25.5
Temp (Deg K) 298.5
Pressure (kPa) 93.45
Relative Humidity (%) 34.3
ACPLA 9.3
Instrument Viral Media Conc. (PFU/ml)Media Volume InitiMedia Volume Final Air Conc. (PFU/Liter of Air)
XMX Unit 2 275000 5 5 409
XMX Unit 3 497500 5 5 740
DFU 14000 15 15 50
SKCc 118 20 19 36
AGI-30c 220 20 14 48
TR 28 -- Low ACPLA (Target ACPLA = 1, Actual ACPLA = 18.4 ) 
Sample Run Time (min) 5
Q (L/min)
XMX Unit 2 Flow Rate 672
XMX Unit 3 Flow Rate 672
DFU Flow Rate 843
Biosampler Flow Rate 12.5
AGI-30 Flow Rate 12.75
Temp (Deg C) 26
Temp (Deg K) 299
Pressure (kPa) 93.3
Relative Humidity (%) 37.6
ACPLA 18.4
Instrument Viral Media Conc. (PFU/ml) Media Vol. Initial Media Vol. Final Air Conc. (PFU/Liter of Air)
XMX Unit 2c 52000 5 5 77
XMX Unit 3c 30250 5 5 45
DFU 13250 15 15 47
SKCc 125 20 18.5 37
AGI-30c 235 20 13 48
cPlate Sample Dilution was Recorded One Order of Magnitude too High. Results Excluded from Analysis
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Appendix 5: Decontamination Comparison Trial Data 
 
 
 
 
 
Decontamination Trial 1: Background 5 (Pre-Exposure Background)
Time (min) 5
Q (L/min)
XMX 2 672
XMX 3 672
DFU 843
Background 05 ACPLA = 0
Instrument Media Conc (PFU/ml) Air Conc. (PFU/Liter of Air)
XMX 2 17.5 0.026
XMX 3 5 0.007
DFU 22.5 0.080
Instrument PCR A Result Cycles A PCR B Result Cycles B
XMX 2 Negative 45 Negative 45
XMX 3 Negative 45 Negative 45
DFU Negative 45 Negative 45
Decontamination Trial 1: Trial 06 (Exposure)
Time (min) 5
Q (L/min)
XMX 2 672
XMX 3 672
DFU 843
Trial Run 06 ACPLA = 93.2
Instrument Media Conc. (PFU/ml) Air Conc. (PFU/Liter of Air)
XMX 2 2150000 3199
XMX 3 3275000 4874
DFU 815000 2900
Instrument PCR A Result Cycles A PCR B Result Cycles B
XMX 2 Positive 29.71 Positive 29.74
XMX 3 Positive 24.58 Positive 24.58
DFU Positive 25.48 Positive 25.66
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Decontamination Trial 1: Background 08 (Post Decontamination)
 Time (min) 5
Q (L/min)
XMX 2 672
XMX 3 672
DFU 843
Background 08 ACPLA = 0
Instrument Media Conc (PFU/ml)  Measurement (PFU/Liter of Air)
XMX 2 12.5 0.019
XMX 3 45 0.067
DFU 12.5 0.044
Instrument PCR A Result Cycles A PCR B Result Cycles B
XMX 2 Negative 45 Negative 45
XMX 3 Negative 45 Negative 45
DFU Negative 45 Negative 45
% Reduction w/ 10% Bleach
XMX 2 99.999
XMX 3 99.999
DFU 99.998
Decontamination Trial 2: Background 17 (Pre-Exposure Background)
Sample Run Tim  5
Collector Q (L/min)
XMX 2 672
XMX 3 672
DFU 843
Background 17 ACPLA = 0
Collector Media Conc (PFU/ml) Air Conc. (PFU/Liter of Air)
XMX Unit 2 0 0.000
XMX Unit 3 0 0.000
DFU 7.5 0.027
Instrument PCR A Result Cycles A PCR B Result Cycles B
XMX Unit 2 Negative 45 Negative 45
XMX Unit 3 Negative 45 Negative 45
DFU Negative 45 Negative 45
 
143 
 
 
 
Decontamination Trial 2: Trial 18 (Exposure)
Time (min) 5
Q (L/min)
XMX 2 672
XMX 3 672
DFU 843
Trial Run 18 ACPLA = 13.9
Collector Media Conc (PFU/ml) Air Conc. (PFU/Liter of Air)
XMX Unit 2 390000 580
XMX Unit 3 512500 763
DFUa 59000 210
Instrument PCR A Result Cycles A PCR B Result Cycles B
XMX Unit 2 Positive 28.52 Positive 28.62
XMX Unit 3 Positive 27.21 Positive 27.51
DFU Positive 30.46 Positive 30.31
Decontamination Trial 2: Background 20 (Post Decontamination)
Time (min) 5
Q (L/min)
XMX 2 672
XMX 3 672
DFU 843
Background 20 ACPLA = 0
Instrument Media Conc. (PFU/ml) Air Conc. (PFU/Liter of Air)
XMX Unit 2 2.5 0.004
XMX Unit 3 5 0.007
DFU 2.5 0.009
Instrument PCR A Result Cycles A PCR B Result Cycles B
XMX Unit 2 Negative 45 Negative 45
XMX Unit 3 Negative 45 Negative 45
DFU Negative 45 Negative 45
% Reduction w/ 10% Bleach
XMX Unit 2 99.999
XMX Unit 3 99.999
DFU 99.996
aCorrected Data
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Decontamination Trial 3: Background 24 (Pre-Exposure Background)
Time (min) 5
Q (L/min)
XMX 2 672
XMX 3 672
DFU 843
Background 24 ACPLA = 0
Instrument Media Conc. (PFU/ml) Air Conc. (PFU/Liter of Air)
XMX Unit 2 0 0.000
XMX Unit 3 2.5 0.004
DFU 5 0.018
Instrument PCR A Result Cycles A PCR B Result Cycles B
XMX 2b N/A N/A
XMX 3b N/A N/A
DFU Negative 45 Negative 45
bPCR Results Not Available for this Sample
Decontamination Trial 3: Trial 25 (Exposure)
Time (min) 5
Q (L/min)
XMX  2 672
XMX 3 672
DFU 843
Trial Run 25 ACPLA = 9.3
Instrument  Media Conc. (PFU/ml) Air Conc. (PFU/Liter of Air)
XMX Unit 2 275000 409
XMX Unit 3 497500 740
DFU 14000 50
Instrument PCR A Result Cycles A PCR B Result Cycles B
XMX Unit 2 Positive 36.37 Positive 34.44
XMX Unit 3 Positive 34.8 Positive 34.82
DFU Positive 33.56 Positive 34.82
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Decontamination Trial 3: Background 27 (Post Decontamination)
Time (min) 5
Q (L/min)
XMX 2 672
XMX 3 672
DFU 843
Background 27 ACPLA = 0
Instrument Media Conc. (PFU/ml) Air Conc. (PFU/Liter of Air)
XMX 2 180 0.268
XMX 3 82.5 0.123
DFU 0 0.000
Instrument PCR A Result Cycles A PCR B Result Cycles B
XMX 2 Positive 36.16 Negative 45
XMX 3 Negative 45 Negative 45
DFU Negative 45 Negative 45
% Reduction w/ 10% Bleach 
XMX 2 99.935
XMX 3 99.983
DFU 100
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Appendix 6: Statistical Analysis 
 
 
                    Ave        
Instrument   N  Median      Rank      Z 
AGI          4   29.39      11.0  -0.32 
Biosampler   4   30.29      10.0  -0.65 
DFU          5   10.19       4.0  -2.98 
XMX 2        5   43.98      16.4   1.64 
XMX 3        5   54.89      18.0   2.24 
                    Overall      23             12.0 
 
H = 13.41  DF = 4  P = 0.009 
 
* NOTE * One or more small samples 
 
Table 26: Kruskal-Wallis Analysis of Air Sampling Equipment Comparison for MS2 
 
 
             
 
Table 27: Dunn's Multiple Comparison Test of Air Sampling Equipment for MS2 
 
 
 
                    Ave 
Instrument   N  Median  Rank      Z 
DFU          4   99.17   4.8  -1.56 
XMX 2        5   99.62   7.5   0.00 
XMX 3        5   99.70   9.7   1.47 
                      Overall      14           7.5 
 
H = 3.11  DF = 2  P = 0.211 
H = 3.13  DF = 2  P = 0.209  (adjusted for ties) 
 
* NOTE * One or more small samples 
 
Table 28: Kruskal-Wallis Analysis of Surface Decontamination by Instrument 
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Ave 
Instrument  N  Median  Rank      Z 
DFU         3   99.99   6.7   1.29 
XMX 2       3   99.99   4.0  -0.77 
XMX 3       3   99.99   4.3  -0.52 
                       Overall     9           5.0 
 
H = 1.69  DF = 2  P = 0.430 
H = 2.38  DF = 2  P = 0.304  (adjusted for ties) 
 
* NOTE * One or more small samples 
 
Table 29: Kruskal-Wallis Analysis of Contamination Reduction between Air Samples 
 
                     
                 Ave 
Instrument   N  Median  Rank      Z 
XMX Dycor    5   36.51   4.4  -2.20 
XMX SAM     10   56.55   9.8   2.20 
Overall     15           8.0 
 
H = 4.86  DF = 1  P = 0.027 
 
Table 30: Kruskal-Wallis Analysis of XMX Dycor Apparatus and XMX SAM Apparatus 
 
 
                               Ave 
Trial Phase           N       Median  Rank      Z 
Background            3  0.000000000   2.7  -1.09 
Post Decontamination  3  0.019000000   4.3   1.09 
Overall               6                3.5 
 
H = 1.19  DF = 1  P = 0.275 
H = 1.23  DF = 1  P = 0.268  (adjusted for ties) 
 
* NOTE * One or more small samples 
 
Table 31: Kruskal-Wallis Analysis of Post-Decon Air Sample vs. Background for XMX 2 
 
 
 
                           Ave 
Trial Phase           N    Median  Rank      Z 
Background            3  0.004000   2.2  -1.75 
Post Decontamination  3  0.067000   4.8   1.75 
                 Overall               6             3.5 
 
H = 3.05  DF = 1  P = 0.081 
H = 3.14  DF = 1  P = 0.077  (adjusted for ties) 
 
Table 32: Kruskal-Wallis Analysis of Post-Decon Air Sample vs. Background for XMX 3 
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                            Ave 
Trial Phase           N    Median  Rank      Z 
Background            3  0.027000   4.3   1.09 
Post Decontamination  3  0.009000   2.7  -1.09 
                 Overall               6             3.5 
 
H = 1.19  DF = 1  P = 0.275 
 
* NOTE * One or more small samples 
 
Table 33: Kruskal-Wallis Analysis of Post-Decon Air Sample vs. Background for DFU 
 
 
 
                  Ave 
                     Trial      N  Median      Rank     Z 
TR 06     51  1.5987     239.6   7.61 
TR 09     51  1.2987     228.4   6.62 
TR 18     51  0.3969     111.9  -3.68 
TR 21     51  0.4500     123.2  -2.68 
TR 25     51  0.3969     102.8  -4.48 
TR 28     51  0.3806     115.2  -3.39 
Overall  306             153.5 
 
H = 128.38  DF = 5  P = 0.000 
H = 129.08  DF = 5  P = 0.000  (adjusted for ties) 
 
Table 34: Kruskal-Wallis Analysis of CMD between Trial Runs 
 
 
 
 
 
Table 35: Dunn's Multiple Comparison Test of CMD's between Trial Runs 
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Appendix 7: Air Sampling Results with Excluded Data 
 
 
 
Figure 33: MS2 Air Sample Collection Relative to ACPLA Present in Chamber with Excluded Data 
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Appendix 8: Air Sample Concentration with Corrected Data 
 
 
 
TR 06 -- High ACPLA (Target ACPLA = 100 , Actual ACPLA =93.2)
Sample Run Time (min) 5
Q (L/min)
XMX Unit 2 Flow Rate 672
XMX Unit 3 Flow Rate 672
DFU Flow Rate 843
Biosampler Flow Rate 12.5
AGI-30 Flow Rate 12.75
Temp (Deg C) 26
Temp (Deg K) 299
Pressure (kPa) 93.83
Relative Humidity (%) 34.3
Instrument Viral Media Conc. (PFU/ml) Media Vol. Initial Media Vol. Final Air Conc. (PFU/Liter of Air)
XMX Unit 2 2150000 5 5 3199
XMX Unit 3 3275000 5 5 4874
DFU 815000 15 15 2900
SKC 10650 20 18.5 3152
AGI-30a 15050 20 12.5 2951
TR 09 -- High ACPLA (Target ACPLA = 100, Actual ACPLA = 74.4 ) 
Sample Run Time (min) 5
Q (L/min)
XMX Unit 2 Flow Rate 672
XMX Unit 3 Flow Rate 672
DFU Flow Rate 843
Biosampler Flow Rate 12.5
AGI-30 Flow Rate 12.75
Temp (Deg C) 25.7
Temp (Deg K) 298.7
Pressure (kPa) 93.77
Relative Humidity (%) 33.6
Instrument Viral Media Conc (PFU/ml) Media Vol. Initial Media Vol. Final Air Conc. (PFU/Liter of Air)
XMX Unit 2 2625000 5 5 3906
XMX Unit 3 1075000 5 5 1600
DFU 430000 15 15 1530
SKC 5575 20 19 1695
AGI-30 11400 20 11 1967
aCorrected
 
151 
 
 
 
 
TR 18 -- Moderate ACPLA (Target ACPLA= 10, Actual ACPLA = 13.9) 
Sample Run Time (min) 5
Q (L/min)
XMX Unit 2 Flow Rate 672
XMX Unit 3 Flow Rate 672
DFU Flow Rate 843
Biosampler Flow Rate 12.5
AGI-30 Flow Rate 12.75
Temp (Deg C) 26.6
Temp (Deg K) 299.6
Pressure (kPa) 92.93
Relative Humidity (%) 30.8
Instrument Viral Media Conc (PFU/ml) Media Vol. Initial Media Vol. Final Air Conc. (PFU/Liter of Air)
XMX Unit 2 390000 5 5 580
XMX Unit 3 512500 5 5 763
DFUa 59000 15 15 210
SKC 1225 20 19 372
AGI-30 1925 20 12.5 377
TR 21 -- Moderate ACPLA (Target ACPLA = 10, Actual ACPLA = 21) 
Sample Run Time (min) 5
Q (L/min)
XMX Unit 2 Flow Rate 672
XMX Unit 3 Flow Rate 672
DFU Flow Rate 843
Biosampler Flow Rate 12.5
AGI-30 Flow Rate 12.75
Temp (Deg C) 26
Temp (Deg K) 299
Pressure (kPa) 92.92
Relative Humidity (%) 30.5
Instrument Viral Media Conc. (PFU/ml) Media Vol. Initial Media Vol. Final Air Conc. (PFU/Liter of Air)
XMX Unit 2 735000 5 5 1094
XMX Unit 3 862500 5 5 1283
DFU 60250 15 15 214
SKC 2500 20 19.5 780
AGI-30 5625 20 12 1059
aCorrected
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TR 25-- Low ACPLA (Target = 1 ACPLA, Actual ACPLA = 9.3) 
Sample Run Time (min) 5
Q (L/min)
XMX Unit 2 Flow Rate 672
XMX Unit 3 Flow Rate 672
DFU Flow Rate 843
Biosampler Flow Rate 12.5
AGI-30 Flow Rate 12.75
Temp (Deg C) 25.5
Temp (Deg K) 298.5
Pressure (kPa) 93.45
Relative Humidity (%) 34.3
Instrument Viral Media Conc. (PFU/ml)Media Volume InitiaMedia Volume Final Air Conc. (PFU/Liter of Air)
XMX Unit 2 275000 5 5 409
XMX Unit 3 497500 5 5 740
DFU 14000 15 15 50
SKCa 1180 20 19 359
AGI-30a 2200 20 14 483
TR 28 -- Low ACPLA (Target ACPLA = 1, Actual ACPLA = 18.4 ) 
Sample Run Time (min) 5
Q (L/min)
XMX Unit 2 Flow Rate 672
XMX Unit 3 Flow Rate 672
DFU Flow Rate 843
Biosampler Flow Rate 12.5
AGI-30 Flow Rate 12.75
Temp (Deg C) 26
Temp (Deg K) 299
Pressure (kPa) 93.3
Relative Humidity (%) 37.6
Instrument Viral Media Conc. (PFU/ml) Media Vol. Initial Media Vol. Final Air Conc. (PFU/Liter of Air)
XMX Unit 2a 520000 5 5 774
XMX Unit 3a 302500 5 5 450
DFU 13250 15 15 47
SKCa 1250 20 18.5 370
AGI-30a 2350 20 13 479
aCorrected
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Appendix 9: Corrected Air Sampling Data Analysis 
 
 
Figure 34: MS2 Air Sample Collection Relative to ACPLA Present in Chamber with Corrected Data 
 
 
 
 
Figure 35: MS2 Collection by High Volume Air Sampling Equipment with Linear Trendlines 
(Corrected Data) 
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Instrument   N  Median  Ave Rank      Z 
AGI          6   29.39      16.3   0.26 
Biosampler   6   30.29      13.8  -0.52 
DFU          6   12.65       5.2  -3.21 
XMX 2        6   46.91      21.2   1.76 
XMX 3        6   53.59      21.0   1.71 
                    Overall      30              15.5 
 
H = 13.36  DF = 4  P = 0.010 
 
Table 36: Kruskal-Wallis Analysis of Air Sampling Equipment Comparison for MS2 (Corrected 
Data) 
 
 
 
Table 37: Dunn's Multiple Comparison Test of Air Sampling Equipment for MS2 (Corrected Data) 
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